Num | GO | Overlap | Size | P Value | Adj. P Value |
1 |
REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT |
470 |
1672 |
2.979e-49 |
1.386e-45 |
2 |
REGULATION OF CELL DIFFERENTIATION |
430 |
1492 |
6.74e-48 |
1.568e-44 |
3 |
NEUROGENESIS |
391 |
1402 |
1.072e-39 |
1.662e-36 |
4 |
REGULATION OF CELLULAR COMPONENT MOVEMENT |
256 |
771 |
2.429e-39 |
2.826e-36 |
5 |
CELL DEVELOPMENT |
387 |
1426 |
2.198e-36 |
2.045e-33 |
6 |
POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS |
380 |
1395 |
4.382e-36 |
3.398e-33 |
7 |
POSITIVE REGULATION OF DEVELOPMENTAL PROCESS |
326 |
1142 |
4.68e-35 |
3.111e-32 |
8 |
REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS |
296 |
1021 |
4.242e-33 |
2.467e-30 |
9 |
CARDIOVASCULAR SYSTEM DEVELOPMENT |
246 |
788 |
5.996e-33 |
2.79e-30 |
10 |
CIRCULATORY SYSTEM DEVELOPMENT |
246 |
788 |
5.996e-33 |
2.79e-30 |
11 |
REGULATION OF CELL DEVELOPMENT |
254 |
836 |
6.594e-32 |
2.789e-29 |
12 |
TISSUE DEVELOPMENT |
390 |
1518 |
4.013e-31 |
1.556e-28 |
13 |
REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION |
413 |
1656 |
5.204e-30 |
1.863e-27 |
14 |
POSITIVE REGULATION OF CELL DIFFERENTIATION |
246 |
823 |
1.036e-29 |
3.444e-27 |
15 |
CELLULAR RESPONSE TO ORGANIC SUBSTANCE |
446 |
1848 |
4.617e-29 |
1.432e-26 |
16 |
LOCOMOTION |
302 |
1114 |
3.592e-28 |
1.045e-25 |
17 |
MOVEMENT OF CELL OR SUBCELLULAR COMPONENT |
333 |
1275 |
7.323e-28 |
2.004e-25 |
18 |
POSITIVE REGULATION OF CELL COMMUNICATION |
382 |
1532 |
1.137e-27 |
2.939e-25 |
19 |
POSITIVE REGULATION OF RESPONSE TO STIMULUS |
455 |
1929 |
2.567e-27 |
6.286e-25 |
20 |
CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND |
235 |
799 |
2.735e-27 |
6.364e-25 |
21 |
NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS |
273 |
983 |
3.033e-27 |
6.721e-25 |
22 |
NEURON DIFFERENTIATION |
250 |
874 |
5.133e-27 |
1.082e-24 |
23 |
REGULATION OF CELL PROLIFERATION |
373 |
1496 |
5.349e-27 |
1.082e-24 |
24 |
RESPONSE TO ENDOGENOUS STIMULUS |
364 |
1450 |
6.285e-27 |
1.219e-24 |
25 |
VASCULATURE DEVELOPMENT |
160 |
469 |
2.995e-26 |
5.574e-24 |
26 |
NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS |
232 |
801 |
6.332e-26 |
1.133e-23 |
27 |
REGULATION OF NERVOUS SYSTEM DEVELOPMENT |
221 |
750 |
8.13e-26 |
1.401e-23 |
28 |
POSITIVE REGULATION OF MOLECULAR FUNCTION |
424 |
1791 |
1.002e-25 |
1.608e-23 |
29 |
RESPONSE TO OXYGEN CONTAINING COMPOUND |
347 |
1381 |
9.92e-26 |
1.608e-23 |
30 |
REGULATION OF NEURON DIFFERENTIATION |
178 |
554 |
1.29e-25 |
2.001e-23 |
31 |
BIOLOGICAL ADHESION |
278 |
1032 |
1.782e-25 |
2.675e-23 |
32 |
INTRACELLULAR SIGNAL TRANSDUCTION |
380 |
1572 |
9.064e-25 |
1.318e-22 |
33 |
CELLULAR RESPONSE TO ENDOGENOUS STIMULUS |
271 |
1008 |
1.059e-24 |
1.493e-22 |
34 |
CELL MOTILITY |
234 |
835 |
5.464e-24 |
7.264e-22 |
35 |
LOCALIZATION OF CELL |
234 |
835 |
5.464e-24 |
7.264e-22 |
36 |
REGULATION OF CELL PROJECTION ORGANIZATION |
174 |
558 |
1.943e-23 |
2.511e-21 |
37 |
REGULATION OF TRANSPORT |
418 |
1804 |
2.154e-23 |
2.709e-21 |
38 |
REGULATION OF CELL MORPHOGENESIS |
171 |
552 |
1.046e-22 |
1.281e-20 |
39 |
NEURON PROJECTION DEVELOPMENT |
169 |
545 |
1.668e-22 |
1.99e-20 |
40 |
NEURON DEVELOPMENT |
199 |
687 |
2.41e-22 |
2.803e-20 |
41 |
REGULATION OF PHOSPHORUS METABOLIC PROCESS |
379 |
1618 |
4.704e-22 |
5.339e-20 |
42 |
POSITIVE REGULATION OF LOCOMOTION |
140 |
420 |
4.989e-22 |
5.527e-20 |
43 |
ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY |
198 |
689 |
8.581e-22 |
9.285e-20 |
44 |
CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
160 |
513 |
1.208e-21 |
1.278e-19 |
45 |
POSITIVE REGULATION OF CATALYTIC ACTIVITY |
359 |
1518 |
1.251e-21 |
1.294e-19 |
46 |
RESPONSE TO WOUNDING |
170 |
563 |
2.84e-21 |
2.873e-19 |
47 |
BLOOD VESSEL MORPHOGENESIS |
125 |
364 |
4.943e-21 |
4.894e-19 |
48 |
RESPONSE TO NITROGEN COMPOUND |
230 |
859 |
8.364e-21 |
8.108e-19 |
49 |
NEURON PROJECTION MORPHOGENESIS |
133 |
402 |
1.161e-20 |
1.092e-18 |
50 |
REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
404 |
1784 |
1.173e-20 |
1.092e-18 |
51 |
REGULATION OF NEURON PROJECTION DEVELOPMENT |
134 |
408 |
1.723e-20 |
1.572e-18 |
52 |
REGULATION OF PROTEIN MODIFICATION PROCESS |
389 |
1710 |
3.053e-20 |
2.732e-18 |
53 |
CELLULAR COMPONENT MORPHOGENESIS |
236 |
900 |
4.488e-20 |
3.94e-18 |
54 |
POSITIVE REGULATION OF GENE EXPRESSION |
392 |
1733 |
6.058e-20 |
5.22e-18 |
55 |
POSITIVE REGULATION OF CELL DEVELOPMENT |
146 |
472 |
1.76e-19 |
1.489e-17 |
56 |
MUSCLE STRUCTURE DEVELOPMENT |
137 |
432 |
2.109e-19 |
1.752e-17 |
57 |
NEGATIVE REGULATION OF CELL DIFFERENTIATION |
175 |
609 |
2.267e-19 |
1.851e-17 |
58 |
REGULATION OF CELL DEATH |
342 |
1472 |
2.664e-19 |
2.137e-17 |
59 |
REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
115 |
337 |
3.3e-19 |
2.603e-17 |
60 |
NEGATIVE REGULATION OF RESPONSE TO STIMULUS |
320 |
1360 |
6.13e-19 |
4.754e-17 |
61 |
HEAD DEVELOPMENT |
194 |
709 |
8.819e-19 |
6.727e-17 |
62 |
HEART DEVELOPMENT |
143 |
466 |
9.235e-19 |
6.821e-17 |
63 |
NEGATIVE REGULATION OF CELL COMMUNICATION |
288 |
1192 |
9.21e-19 |
6.821e-17 |
64 |
POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS |
258 |
1036 |
1.178e-18 |
8.436e-17 |
65 |
POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS |
258 |
1036 |
1.178e-18 |
8.436e-17 |
66 |
CENTRAL NERVOUS SYSTEM DEVELOPMENT |
226 |
872 |
1.339e-18 |
9.442e-17 |
67 |
CELLULAR RESPONSE TO NITROGEN COMPOUND |
151 |
505 |
1.389e-18 |
9.646e-17 |
68 |
POSITIVE REGULATION OF CELL PROLIFERATION |
214 |
814 |
2.038e-18 |
1.394e-16 |
69 |
WOUND HEALING |
143 |
470 |
2.143e-18 |
1.445e-16 |
70 |
POSITIVE REGULATION OF BIOSYNTHETIC PROCESS |
398 |
1805 |
3.11e-18 |
2.067e-16 |
71 |
POSITIVE REGULATION OF HYDROLASE ACTIVITY |
230 |
905 |
8.101e-18 |
5.309e-16 |
72 |
ORGAN MORPHOGENESIS |
217 |
841 |
1.174e-17 |
7.588e-16 |
73 |
POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT |
134 |
437 |
1.258e-17 |
8.017e-16 |
74 |
ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS |
239 |
957 |
1.71e-17 |
1.076e-15 |
75 |
RESPONSE TO ORGANIC CYCLIC COMPOUND |
231 |
917 |
2.094e-17 |
1.299e-15 |
76 |
POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
247 |
1004 |
3.408e-17 |
2.086e-15 |
77 |
REGULATION OF CELL ADHESION |
173 |
629 |
4.26e-17 |
2.574e-15 |
78 |
SINGLE ORGANISM BEHAVIOR |
121 |
384 |
4.824e-17 |
2.878e-15 |
79 |
POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION |
274 |
1152 |
6.272e-17 |
3.694e-15 |
80 |
REGULATION OF SYSTEM PROCESS |
147 |
507 |
8.004e-17 |
4.655e-15 |
81 |
POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS |
335 |
1492 |
1.452e-16 |
8.342e-15 |
82 |
REGULATION OF BODY FLUID LEVELS |
146 |
506 |
1.617e-16 |
9.173e-15 |
83 |
BEHAVIOR |
148 |
516 |
1.76e-16 |
9.867e-15 |
84 |
TAXIS |
137 |
464 |
1.799e-16 |
9.963e-15 |
85 |
CELL PROJECTION ORGANIZATION |
225 |
902 |
1.859e-16 |
1.018e-14 |
86 |
RESPONSE TO LIPID |
222 |
888 |
2.3e-16 |
1.244e-14 |
87 |
POSITIVE REGULATION OF TRANSPORT |
231 |
936 |
2.66e-16 |
1.423e-14 |
88 |
POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION |
219 |
876 |
3.717e-16 |
1.966e-14 |
89 |
NEGATIVE REGULATION OF CELL PROLIFERATION |
173 |
643 |
4.213e-16 |
2.203e-14 |
90 |
REGULATION OF GTPASE ACTIVITY |
179 |
673 |
4.28e-16 |
2.213e-14 |
91 |
RESPONSE TO HORMONE |
222 |
893 |
4.484e-16 |
2.293e-14 |
92 |
SKELETAL SYSTEM DEVELOPMENT |
134 |
455 |
4.857e-16 |
2.457e-14 |
93 |
MUSCLE TISSUE DEVELOPMENT |
94 |
275 |
5.346e-16 |
2.675e-14 |
94 |
CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION |
115 |
368 |
5.709e-16 |
2.826e-14 |
95 |
POSITIVE REGULATION OF NEURON DIFFERENTIATION |
101 |
306 |
6.315e-16 |
3.093e-14 |
96 |
PROTEIN PHOSPHORYLATION |
231 |
944 |
7.464e-16 |
3.618e-14 |
97 |
EPITHELIUM DEVELOPMENT |
231 |
945 |
8.478e-16 |
4.067e-14 |
98 |
RESPONSE TO EXTERNAL STIMULUS |
390 |
1821 |
9.863e-16 |
4.683e-14 |
99 |
FOREBRAIN DEVELOPMENT |
112 |
357 |
1.01e-15 |
4.745e-14 |
100 |
TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY |
142 |
498 |
1.246e-15 |
5.795e-14 |
101 |
POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS |
266 |
1135 |
1.301e-15 |
5.995e-14 |
102 |
CELLULAR RESPONSE TO LIPID |
133 |
457 |
1.764e-15 |
8.045e-14 |
103 |
REGULATION OF HYDROLASE ACTIVITY |
300 |
1327 |
2.694e-15 |
1.217e-13 |
104 |
REGULATION OF MAPK CASCADE |
174 |
660 |
2.735e-15 |
1.224e-13 |
105 |
REGULATION OF CELLULAR COMPONENT BIOGENESIS |
195 |
767 |
2.863e-15 |
1.269e-13 |
106 |
REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY |
82 |
232 |
4.576e-15 |
2.008e-13 |
107 |
ANGIOGENESIS |
96 |
293 |
5.6e-15 |
2.435e-13 |
108 |
TUBE DEVELOPMENT |
151 |
552 |
7.43e-15 |
3.201e-13 |
109 |
REGULATION OF ION TRANSPORT |
158 |
592 |
1.759e-14 |
7.507e-13 |
110 |
REGULATION OF MEMBRANE POTENTIAL |
106 |
343 |
1.819e-14 |
7.694e-13 |
111 |
REGULATION OF METAL ION TRANSPORT |
102 |
325 |
1.883e-14 |
7.894e-13 |
112 |
REGULATION OF EPITHELIAL CELL PROLIFERATION |
93 |
285 |
1.967e-14 |
8.172e-13 |
113 |
CELLULAR RESPONSE TO HORMONE STIMULUS |
149 |
552 |
3.702e-14 |
1.524e-12 |
114 |
REGULATION OF KINASE ACTIVITY |
193 |
776 |
3.965e-14 |
1.618e-12 |
115 |
NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
186 |
740 |
4.106e-14 |
1.661e-12 |
116 |
POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION |
96 |
303 |
5.802e-14 |
2.327e-12 |
117 |
REGULATION OF CELLULAR LOCALIZATION |
284 |
1277 |
1.326e-13 |
5.275e-12 |
118 |
POSITIVE REGULATION OF KINASE ACTIVITY |
133 |
482 |
1.537e-13 |
6.061e-12 |
119 |
REGULATION OF OSSIFICATION |
66 |
178 |
1.614e-13 |
6.31e-12 |
120 |
UROGENITAL SYSTEM DEVELOPMENT |
94 |
299 |
1.781e-13 |
6.905e-12 |
121 |
REGULATION OF BLOOD CIRCULATION |
93 |
295 |
1.994e-13 |
7.669e-12 |
122 |
COGNITION |
83 |
251 |
2.191e-13 |
8.355e-12 |
123 |
CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND |
129 |
465 |
2.347e-13 |
8.878e-12 |
124 |
RESPONSE TO GROWTH FACTOR |
131 |
475 |
2.448e-13 |
9.187e-12 |
125 |
RESPONSE TO OXYGEN LEVELS |
96 |
311 |
3.372e-13 |
1.255e-11 |
126 |
CELL PART MORPHOGENESIS |
162 |
633 |
3.89e-13 |
1.436e-11 |
127 |
REGULATION OF CELL SUBSTRATE ADHESION |
64 |
173 |
4.231e-13 |
1.55e-11 |
128 |
CONNECTIVE TISSUE DEVELOPMENT |
69 |
194 |
4.716e-13 |
1.708e-11 |
129 |
TELENCEPHALON DEVELOPMENT |
77 |
228 |
4.736e-13 |
1.708e-11 |
130 |
NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS |
143 |
541 |
7.088e-13 |
2.518e-11 |
131 |
NEGATIVE REGULATION OF PHOSPHATE METABOLIC PROCESS |
143 |
541 |
7.088e-13 |
2.518e-11 |
132 |
RESPONSE TO PEPTIDE |
115 |
404 |
7.471e-13 |
2.614e-11 |
133 |
MODULATION OF SYNAPTIC TRANSMISSION |
93 |
301 |
7.423e-13 |
2.614e-11 |
134 |
NEGATIVE REGULATION OF GENE EXPRESSION |
319 |
1493 |
8.129e-13 |
2.823e-11 |
135 |
REGULATION OF DENDRITE DEVELOPMENT |
50 |
120 |
8.407e-13 |
2.897e-11 |
136 |
REGULATION OF PROTEIN LOCALIZATION |
221 |
950 |
8.786e-13 |
3.006e-11 |
137 |
ACTIN FILAMENT BASED PROCESS |
124 |
450 |
1.145e-12 |
3.889e-11 |
138 |
POSITIVE REGULATION OF CELL DEATH |
155 |
605 |
1.16e-12 |
3.91e-11 |
139 |
CHEMICAL HOMEOSTASIS |
206 |
874 |
1.488e-12 |
4.982e-11 |
140 |
MUSCLE CELL DIFFERENTIATION |
78 |
237 |
1.516e-12 |
5.037e-11 |
141 |
PALLIUM DEVELOPMENT |
58 |
153 |
1.604e-12 |
5.292e-11 |
142 |
PHOSPHATE CONTAINING COMPOUND METABOLIC PROCESS |
401 |
1977 |
1.962e-12 |
6.43e-11 |
143 |
GROWTH |
115 |
410 |
2.165e-12 |
7.045e-11 |
144 |
POSITIVE REGULATION OF MAPK CASCADE |
127 |
470 |
2.715e-12 |
8.773e-11 |
145 |
REGULATION OF ACTIN FILAMENT BASED PROCESS |
94 |
312 |
2.831e-12 |
9.085e-11 |
146 |
NEGATIVE REGULATION OF CELL ADHESION |
74 |
223 |
3.578e-12 |
1.14e-10 |
147 |
NEGATIVE REGULATION OF LOCOMOTION |
83 |
263 |
3.671e-12 |
1.162e-10 |
148 |
POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT |
76 |
232 |
3.795e-12 |
1.193e-10 |
149 |
NEGATIVE REGULATION OF TRANSPORT |
124 |
458 |
4.266e-12 |
1.332e-10 |
150 |
TISSUE MORPHOGENESIS |
139 |
533 |
4.362e-12 |
1.353e-10 |
151 |
POSITIVE REGULATION OF OSSIFICATION |
39 |
84 |
4.648e-12 |
1.432e-10 |
152 |
REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION |
86 |
278 |
5.014e-12 |
1.529e-10 |
153 |
REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY |
70 |
207 |
5.027e-12 |
1.529e-10 |
154 |
REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY |
126 |
470 |
5.965e-12 |
1.802e-10 |
155 |
REGULATION OF EPITHELIAL CELL MIGRATION |
60 |
166 |
7.093e-12 |
2.129e-10 |
156 |
NEURON PROJECTION GUIDANCE |
69 |
205 |
9.101e-12 |
2.714e-10 |
157 |
CELL CELL SIGNALING |
183 |
767 |
9.306e-12 |
2.758e-10 |
158 |
RESPONSE TO MECHANICAL STIMULUS |
70 |
210 |
1.076e-11 |
3.169e-10 |
159 |
MORPHOGENESIS OF AN EPITHELIUM |
111 |
400 |
1.092e-11 |
3.194e-10 |
160 |
IMMUNE SYSTEM PROCESS |
398 |
1984 |
1.193e-11 |
3.47e-10 |
161 |
EMBRYO DEVELOPMENT |
206 |
894 |
1.385e-11 |
4.003e-10 |
162 |
CELLULAR RESPONSE TO PEPTIDE |
84 |
274 |
1.496e-11 |
4.297e-10 |
163 |
CELL ACTIVATION |
144 |
568 |
1.71e-11 |
4.881e-10 |
164 |
REGULATION OF HOMEOSTATIC PROCESS |
120 |
447 |
1.731e-11 |
4.912e-10 |
165 |
REGULATION OF ANATOMICAL STRUCTURE SIZE |
125 |
472 |
1.763e-11 |
4.971e-10 |
166 |
REGULATION OF HEART CONTRACTION |
72 |
221 |
1.86e-11 |
5.214e-10 |
167 |
HOMEOSTATIC PROCESS |
285 |
1337 |
2.04e-11 |
5.685e-10 |
168 |
EXTRACELLULAR STRUCTURE ORGANIZATION |
90 |
304 |
2.356e-11 |
6.527e-10 |
169 |
NEGATIVE REGULATION OF NITROGEN COMPOUND METABOLIC PROCESS |
316 |
1517 |
2.602e-11 |
7.165e-10 |
170 |
DEVELOPMENTAL GROWTH |
96 |
333 |
2.702e-11 |
7.396e-10 |
171 |
MUSCLE ORGAN DEVELOPMENT |
84 |
277 |
2.798e-11 |
7.613e-10 |
172 |
IMMUNE SYSTEM DEVELOPMENT |
146 |
582 |
2.836e-11 |
7.671e-10 |
173 |
RESPONSE TO ALCOHOL |
102 |
362 |
2.852e-11 |
7.671e-10 |
174 |
REGULATION OF ION HOMEOSTASIS |
67 |
201 |
2.961e-11 |
7.919e-10 |
175 |
RESPONSE TO ABIOTIC STIMULUS |
228 |
1024 |
3.692e-11 |
9.651e-10 |
176 |
CARDIOCYTE DIFFERENTIATION |
41 |
96 |
3.66e-11 |
9.651e-10 |
177 |
NEGATIVE REGULATION OF PHOSPHORYLATION |
114 |
422 |
3.645e-11 |
9.651e-10 |
178 |
HEMOSTASIS |
91 |
311 |
3.684e-11 |
9.651e-10 |
179 |
NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION |
117 |
437 |
3.732e-11 |
9.702e-10 |
180 |
RHYTHMIC PROCESS |
88 |
298 |
4.543e-11 |
1.174e-09 |
181 |
PHOSPHORYLATION |
264 |
1228 |
4.822e-11 |
1.239e-09 |
182 |
REGULATION OF GROWTH |
155 |
633 |
4.937e-11 |
1.262e-09 |
183 |
STRIATED MUSCLE CELL DIFFERENTIATION |
60 |
173 |
5.085e-11 |
1.293e-09 |
184 |
REGULATION OF CATION TRANSMEMBRANE TRANSPORT |
68 |
208 |
5.638e-11 |
1.426e-09 |
185 |
REGULATION OF MUSCLE SYSTEM PROCESS |
65 |
195 |
5.814e-11 |
1.462e-09 |
186 |
REGULATION OF TRANSFERASE ACTIVITY |
213 |
946 |
5.87e-11 |
1.468e-09 |
187 |
REGULATION OF TRANSMEMBRANE TRANSPORT |
114 |
426 |
6.87e-11 |
1.71e-09 |
188 |
EMBRYONIC MORPHOGENESIS |
136 |
539 |
8.931e-11 |
2.21e-09 |
189 |
MORPHOGENESIS OF A BRANCHING STRUCTURE |
58 |
167 |
9.958e-11 |
2.452e-09 |
190 |
REGULATION OF VASCULATURE DEVELOPMENT |
73 |
233 |
1.05e-10 |
2.571e-09 |
191 |
REGULATION OF IMMUNE SYSTEM PROCESS |
293 |
1403 |
1.124e-10 |
2.739e-09 |
192 |
CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT |
33 |
70 |
1.215e-10 |
2.944e-09 |
193 |
CIRCULATORY SYSTEM PROCESS |
101 |
366 |
1.306e-10 |
3.15e-09 |
194 |
RESPONSE TO STEROID HORMONE |
127 |
497 |
1.568e-10 |
3.761e-09 |
195 |
REGULATION OF SYNAPTIC PLASTICITY |
51 |
140 |
1.884e-10 |
4.495e-09 |
196 |
REGULATION OF RESPONSE TO WOUNDING |
110 |
413 |
2.008e-10 |
4.766e-09 |
197 |
REGULATION OF RESPONSE TO EXTERNAL STIMULUS |
207 |
926 |
2.159e-10 |
5.1e-09 |
198 |
NEGATIVE REGULATION OF CELL DEATH |
197 |
872 |
2.373e-10 |
5.576e-09 |
199 |
CEREBRAL CORTEX DEVELOPMENT |
42 |
105 |
2.598e-10 |
6.075e-09 |
200 |
NEGATIVE REGULATION OF CELL DEVELOPMENT |
87 |
303 |
2.859e-10 |
6.65e-09 |
201 |
REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS |
71 |
229 |
3.171e-10 |
7.34e-09 |
202 |
REGULATION OF TRANSPORTER ACTIVITY |
64 |
198 |
3.492e-10 |
8.044e-09 |
203 |
SENSORY ORGAN DEVELOPMENT |
125 |
493 |
3.726e-10 |
8.54e-09 |
204 |
REGULATION OF MAP KINASE ACTIVITY |
90 |
319 |
3.844e-10 |
8.768e-09 |
205 |
GLOMERULUS DEVELOPMENT |
26 |
49 |
4.223e-10 |
9.586e-09 |
206 |
CARTILAGE DEVELOPMENT |
52 |
147 |
4.29e-10 |
9.69e-09 |
207 |
REGULATION OF SECRETION |
164 |
699 |
4.432e-10 |
9.963e-09 |
208 |
SECOND MESSENGER MEDIATED SIGNALING |
55 |
160 |
4.672e-10 |
1.045e-08 |
209 |
MUSCLE SYSTEM PROCESS |
82 |
282 |
4.732e-10 |
1.054e-08 |
210 |
POSITIVE REGULATION OF ION TRANSPORT |
72 |
236 |
5.316e-10 |
1.178e-08 |
211 |
POSITIVE REGULATION OF TRANSFERASE ACTIVITY |
148 |
616 |
5.681e-10 |
1.253e-08 |
212 |
REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION |
40 |
100 |
6.882e-10 |
1.51e-08 |
213 |
CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION |
56 |
166 |
7.297e-10 |
1.594e-08 |
214 |
SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION |
96 |
352 |
7.393e-10 |
1.6e-08 |
215 |
ION HOMEOSTASIS |
140 |
576 |
7.36e-10 |
1.6e-08 |
216 |
POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION |
53 |
154 |
9.16e-10 |
1.973e-08 |
217 |
REGULATION OF CHEMOTAXIS |
59 |
180 |
9.205e-10 |
1.974e-08 |
218 |
REGULATION OF RESPONSE TO STRESS |
299 |
1468 |
1.19e-09 |
2.539e-08 |
219 |
MESENCHYME DEVELOPMENT |
61 |
190 |
1.211e-09 |
2.572e-08 |
220 |
CELL SUBSTRATE ADHESION |
55 |
164 |
1.319e-09 |
2.79e-08 |
221 |
RESPONSE TO DRUG |
111 |
431 |
1.386e-09 |
2.919e-08 |
222 |
NEURON MIGRATION |
42 |
110 |
1.418e-09 |
2.972e-08 |
223 |
REGULATION OF DEVELOPMENTAL GROWTH |
82 |
289 |
1.712e-09 |
3.572e-08 |
224 |
POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION |
40 |
103 |
1.936e-09 |
4.022e-08 |
225 |
REGULATION OF PROTEIN SECRETION |
102 |
389 |
2.284e-09 |
4.724e-08 |
226 |
CELLULAR CHEMICAL HOMEOSTASIS |
137 |
570 |
2.433e-09 |
5.009e-08 |
227 |
GLAND DEVELOPMENT |
103 |
395 |
2.639e-09 |
5.409e-08 |
228 |
AMEBOIDAL TYPE CELL MIGRATION |
52 |
154 |
2.812e-09 |
5.739e-08 |
229 |
CELL JUNCTION ORGANIZATION |
59 |
185 |
2.986e-09 |
6.068e-08 |
230 |
STEM CELL DIFFERENTIATION |
60 |
190 |
3.359e-09 |
6.796e-08 |
231 |
CARDIAC MUSCLE CELL DIFFERENTIATION |
32 |
74 |
3.472e-09 |
6.994e-08 |
232 |
MULTI MULTICELLULAR ORGANISM PROCESS |
65 |
213 |
3.577e-09 |
7.173e-08 |
233 |
NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS |
98 |
372 |
3.61e-09 |
7.209e-08 |
234 |
REGULATION OF STEM CELL DIFFERENTIATION |
42 |
113 |
3.668e-09 |
7.294e-08 |
235 |
TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
165 |
724 |
3.725e-09 |
7.375e-08 |
236 |
REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING |
48 |
138 |
3.763e-09 |
7.419e-08 |
237 |
TUBE MORPHOGENESIS |
88 |
323 |
3.95e-09 |
7.754e-08 |
238 |
REGULATION OF CALCIUM ION TRANSPORT |
64 |
209 |
4.042e-09 |
7.903e-08 |
239 |
RESPONSE TO CYTOKINE |
163 |
714 |
4.083e-09 |
7.949e-08 |
240 |
OSSIFICATION |
73 |
251 |
4.147e-09 |
8.041e-08 |
241 |
REGULATION OF ORGAN MORPHOGENESIS |
71 |
242 |
4.492e-09 |
8.673e-08 |
242 |
REGULATION OF CELL MATRIX ADHESION |
36 |
90 |
4.837e-09 |
9.301e-08 |
243 |
RESPONSE TO TRANSFORMING GROWTH FACTOR BETA |
49 |
144 |
5.973e-09 |
1.144e-07 |
244 |
NEPHRON DEVELOPMENT |
42 |
115 |
6.736e-09 |
1.279e-07 |
245 |
NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS |
144 |
616 |
6.714e-09 |
1.279e-07 |
246 |
POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
53 |
162 |
6.961e-09 |
1.317e-07 |
247 |
SKELETAL MUSCLE ORGAN DEVELOPMENT |
47 |
137 |
9.014e-09 |
1.698e-07 |
248 |
CELL CELL ADHESION |
142 |
608 |
9.101e-09 |
1.708e-07 |
249 |
REGULATION OF HEMOPOIESIS |
85 |
314 |
1.003e-08 |
1.873e-07 |
250 |
FOREBRAIN CELL MIGRATION |
28 |
62 |
1.016e-08 |
1.891e-07 |
251 |
POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS |
103 |
406 |
1.266e-08 |
2.344e-07 |
252 |
APPENDAGE DEVELOPMENT |
54 |
169 |
1.275e-08 |
2.344e-07 |
253 |
LIMB DEVELOPMENT |
54 |
169 |
1.275e-08 |
2.344e-07 |
254 |
REGULATION OF MUSCLE CONTRACTION |
49 |
147 |
1.285e-08 |
2.355e-07 |
255 |
REGULATION OF PROTEIN IMPORT |
57 |
183 |
1.428e-08 |
2.606e-07 |
256 |
REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT |
65 |
220 |
1.472e-08 |
2.676e-07 |
257 |
CELL PROLIFERATION |
153 |
672 |
1.487e-08 |
2.692e-07 |
258 |
REGULATION OF DENDRITE MORPHOGENESIS |
31 |
74 |
1.524e-08 |
2.731e-07 |
259 |
SINGLE ORGANISM CELL ADHESION |
113 |
459 |
1.526e-08 |
2.731e-07 |
260 |
LEUKOCYTE DIFFERENTIATION |
80 |
292 |
1.517e-08 |
2.731e-07 |
261 |
REGULATION OF CELLULAR COMPONENT SIZE |
89 |
337 |
1.642e-08 |
2.927e-07 |
262 |
RENAL SYSTEM PROCESS |
38 |
102 |
1.86e-08 |
3.304e-07 |
263 |
REGULATION OF ENDOTHELIAL CELL PROLIFERATION |
37 |
98 |
1.885e-08 |
3.334e-07 |
264 |
DIVALENT INORGANIC CATION HOMEOSTASIS |
90 |
343 |
1.908e-08 |
3.362e-07 |
265 |
SECRETION |
137 |
588 |
1.944e-08 |
3.414e-07 |
266 |
CELL CHEMOTAXIS |
52 |
162 |
1.983e-08 |
3.469e-07 |
267 |
POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY |
79 |
289 |
2.073e-08 |
3.612e-07 |
268 |
CELLULAR HOMEOSTASIS |
153 |
676 |
2.245e-08 |
3.897e-07 |
269 |
REGULATION OF PHOSPHOLIPASE ACTIVITY |
28 |
64 |
2.4e-08 |
4.152e-07 |
270 |
REGULATION OF PEPTIDE TRANSPORT |
72 |
256 |
2.455e-08 |
4.23e-07 |
271 |
REGULATION OF POTASSIUM ION TRANSPORT |
33 |
83 |
2.496e-08 |
4.286e-07 |
272 |
CELL DEATH |
211 |
1001 |
2.536e-08 |
4.337e-07 |
273 |
EMBRYONIC ORGAN DEVELOPMENT |
102 |
406 |
2.547e-08 |
4.341e-07 |
274 |
REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC |
24 |
50 |
2.623e-08 |
4.454e-07 |
275 |
EPITHELIAL CELL DIFFERENTIATION |
119 |
495 |
2.69e-08 |
4.551e-07 |
276 |
REGULATION OF AXONOGENESIS |
53 |
168 |
2.809e-08 |
4.735e-07 |
277 |
CARDIAC MUSCLE CELL ACTION POTENTIAL |
20 |
37 |
2.928e-08 |
4.918e-07 |
278 |
NEGATIVE REGULATION OF NEURON DIFFERENTIATION |
58 |
191 |
2.963e-08 |
4.96e-07 |
279 |
REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT |
41 |
116 |
2.997e-08 |
4.999e-07 |
280 |
NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT |
73 |
262 |
3.009e-08 |
5e-07 |
281 |
REGULATION OF OSTEOBLAST DIFFERENTIATION |
40 |
112 |
3.155e-08 |
5.225e-07 |
282 |
REGULATION OF CYTOPLASMIC TRANSPORT |
116 |
481 |
3.345e-08 |
5.52e-07 |
283 |
REGULATION OF INTRACELLULAR TRANSPORT |
142 |
621 |
3.717e-08 |
6.111e-07 |
284 |
REGULATION OF MYELOID CELL DIFFERENTIATION |
56 |
183 |
3.792e-08 |
6.213e-07 |
285 |
MESENCHYMAL CELL DIFFERENTIATION |
45 |
134 |
3.858e-08 |
6.298e-07 |
286 |
AGING |
73 |
264 |
4.23e-08 |
6.882e-07 |
287 |
REGULATION OF MUSCLE CELL DIFFERENTIATION |
49 |
152 |
4.314e-08 |
6.995e-07 |
288 |
REGULATION OF CELL SHAPE |
46 |
139 |
4.541e-08 |
7.336e-07 |
289 |
REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION |
56 |
184 |
4.675e-08 |
7.527e-07 |
290 |
POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS |
186 |
867 |
4.752e-08 |
7.624e-07 |
291 |
SUBSTRATE ADHESION DEPENDENT CELL SPREADING |
20 |
38 |
5.321e-08 |
8.507e-07 |
292 |
POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT |
44 |
131 |
5.409e-08 |
8.619e-07 |
293 |
REGULATION OF WNT SIGNALING PATHWAY |
82 |
310 |
5.507e-08 |
8.746e-07 |
294 |
REGULATION OF ENDOTHELIAL CELL MIGRATION |
40 |
114 |
5.543e-08 |
8.773e-07 |
295 |
CARDIAC MUSCLE TISSUE DEVELOPMENT |
46 |
140 |
5.802e-08 |
9.152e-07 |
296 |
REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS |
63 |
218 |
6.06e-08 |
9.525e-07 |
297 |
REGULATION OF FAT CELL DIFFERENTIATION |
38 |
106 |
6.161e-08 |
9.619e-07 |
298 |
FAT CELL DIFFERENTIATION |
38 |
106 |
6.161e-08 |
9.619e-07 |
299 |
LOCOMOTORY BEHAVIOR |
55 |
181 |
6.515e-08 |
1.014e-06 |
300 |
REGULATION OF NEURON DEATH |
70 |
252 |
6.544e-08 |
1.015e-06 |
301 |
CARDIAC CONDUCTION |
32 |
82 |
6.823e-08 |
1.055e-06 |
302 |
EPITHELIAL CELL DEVELOPMENT |
56 |
186 |
7.055e-08 |
1.087e-06 |
303 |
REGULATION OF ERK1 AND ERK2 CASCADE |
67 |
238 |
7.128e-08 |
1.095e-06 |
304 |
POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION |
28 |
67 |
7.985e-08 |
1.222e-06 |
305 |
CARDIAC CELL DEVELOPMENT |
23 |
49 |
8.634e-08 |
1.317e-06 |
306 |
REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY |
36 |
99 |
8.963e-08 |
1.358e-06 |
307 |
REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS |
36 |
99 |
8.963e-08 |
1.358e-06 |
308 |
LEUKOCYTE MIGRATION |
71 |
259 |
9.365e-08 |
1.415e-06 |
309 |
REGULATION OF SMOOTH MUSCLE CONTRACTION |
26 |
60 |
9.568e-08 |
1.436e-06 |
310 |
POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION |
26 |
60 |
9.568e-08 |
1.436e-06 |
311 |
KIDNEY EPITHELIUM DEVELOPMENT |
42 |
125 |
1.064e-07 |
1.591e-06 |
312 |
NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION |
24 |
53 |
1.07e-07 |
1.595e-06 |
313 |
CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS |
17 |
30 |
1.284e-07 |
1.908e-06 |
314 |
NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT |
31 |
80 |
1.316e-07 |
1.95e-06 |
315 |
REGULATION OF SYNAPSE ORGANIZATION |
39 |
113 |
1.34e-07 |
1.979e-06 |
316 |
POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS |
78 |
296 |
1.366e-07 |
2.011e-06 |
317 |
REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION |
38 |
109 |
1.432e-07 |
2.101e-06 |
318 |
RESPONSE TO ESTROGEN |
62 |
218 |
1.449e-07 |
2.12e-06 |
319 |
NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION |
46 |
144 |
1.495e-07 |
2.181e-06 |
320 |
GLAND MORPHOGENESIS |
35 |
97 |
1.68e-07 |
2.442e-06 |
321 |
PEPTIDYL TYROSINE MODIFICATION |
55 |
186 |
1.785e-07 |
2.588e-06 |
322 |
CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION |
19 |
37 |
1.918e-07 |
2.772e-06 |
323 |
MEMORY |
35 |
98 |
2.244e-07 |
3.222e-06 |
324 |
MUSCLE CELL DEVELOPMENT |
42 |
128 |
2.243e-07 |
3.222e-06 |
325 |
REPRODUCTIVE SYSTEM DEVELOPMENT |
99 |
408 |
2.455e-07 |
3.514e-06 |
326 |
NEGATIVE REGULATION OF GROWTH |
65 |
236 |
2.668e-07 |
3.808e-06 |
327 |
RESPONSE TO MOLECULE OF BACTERIAL ORIGIN |
82 |
321 |
2.755e-07 |
3.92e-06 |
328 |
CELL JUNCTION ASSEMBLY |
42 |
129 |
2.855e-07 |
4.049e-06 |
329 |
POSITIVE REGULATION OF DEVELOPMENTAL GROWTH |
48 |
156 |
2.886e-07 |
4.082e-06 |
330 |
REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION |
58 |
203 |
3.047e-07 |
4.296e-06 |
331 |
CELLULAR RESPONSE TO ACID CHEMICAL |
52 |
175 |
3.226e-07 |
4.535e-06 |
332 |
CELLULAR RESPONSE TO OXYGEN LEVELS |
45 |
143 |
3.295e-07 |
4.617e-06 |
333 |
REGULATION OF HORMONE SECRETION |
70 |
262 |
3.353e-07 |
4.685e-06 |
334 |
PROTEIN LOCALIZATION |
341 |
1805 |
3.472e-07 |
4.837e-06 |
335 |
ARTERY DEVELOPMENT |
29 |
75 |
3.497e-07 |
4.858e-06 |
336 |
SPROUTING ANGIOGENESIS |
21 |
45 |
3.55e-07 |
4.916e-06 |
337 |
NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS |
220 |
1087 |
3.562e-07 |
4.918e-06 |
338 |
POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY |
35 |
100 |
3.938e-07 |
5.422e-06 |
339 |
ADULT BEHAVIOR |
43 |
135 |
4.109e-07 |
5.64e-06 |
340 |
REGULATED EXOCYTOSIS |
62 |
224 |
4.134e-07 |
5.658e-06 |
341 |
REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL |
33 |
92 |
4.389e-07 |
5.98e-06 |
342 |
RESPONSE TO PURINE CONTAINING COMPOUND |
48 |
158 |
4.396e-07 |
5.98e-06 |
343 |
LEARNING |
42 |
131 |
4.573e-07 |
6.167e-06 |
344 |
ACTIVATION OF PROTEIN KINASE ACTIVITY |
73 |
279 |
4.569e-07 |
6.167e-06 |
345 |
BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE |
42 |
131 |
4.573e-07 |
6.167e-06 |
346 |
RESPONSE TO REACTIVE OXYGEN SPECIES |
55 |
191 |
4.628e-07 |
6.223e-06 |
347 |
POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION |
27 |
68 |
4.708e-07 |
6.314e-06 |
348 |
CYTOSKELETON ORGANIZATION |
176 |
838 |
4.843e-07 |
6.475e-06 |
349 |
POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY |
23 |
53 |
5.054e-07 |
6.738e-06 |
350 |
LEUKOCYTE ACTIVATION |
99 |
414 |
5.073e-07 |
6.744e-06 |
351 |
REGULATION OF HORMONE LEVELS |
111 |
478 |
5.096e-07 |
6.755e-06 |
352 |
SYNAPSE ORGANIZATION |
45 |
145 |
5.117e-07 |
6.764e-06 |
353 |
REGULATION OF CELL ACTIVATION |
112 |
484 |
5.453e-07 |
7.188e-06 |
354 |
POSITIVE REGULATION OF CATION TRANSMEMBRANE TRANSPORT |
34 |
97 |
5.52e-07 |
7.255e-06 |
355 |
REGULATION OF PHOSPHOLIPASE C ACTIVITY |
19 |
39 |
5.55e-07 |
7.271e-06 |
356 |
REGULATION OF NEURON APOPTOTIC PROCESS |
55 |
192 |
5.563e-07 |
7.271e-06 |
357 |
MULTICELLULAR ORGANISMAL SIGNALING |
40 |
123 |
5.615e-07 |
7.317e-06 |
358 |
RESPONSE TO OXIDATIVE STRESS |
87 |
352 |
5.63e-07 |
7.317e-06 |
359 |
CYCLIC NUCLEOTIDE METABOLIC PROCESS |
24 |
57 |
5.652e-07 |
7.325e-06 |
360 |
RESPIRATORY SYSTEM DEVELOPMENT |
56 |
197 |
5.796e-07 |
7.492e-06 |
361 |
ACTIN FILAMENT BASED MOVEMENT |
33 |
93 |
5.844e-07 |
7.533e-06 |
362 |
MEMBRANE DEPOLARIZATION |
25 |
61 |
6.119e-07 |
7.865e-06 |
363 |
CELL MATRIX ADHESION |
39 |
119 |
6.192e-07 |
7.938e-06 |
364 |
CELLULAR RESPONSE TO INSULIN STIMULUS |
45 |
146 |
6.348e-07 |
8.115e-06 |
365 |
NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY |
35 |
102 |
6.768e-07 |
8.628e-06 |
366 |
PLASMA MEMBRANE ORGANIZATION |
57 |
203 |
7.171e-07 |
9.116e-06 |
367 |
BONE DEVELOPMENT |
47 |
156 |
7.526e-07 |
9.542e-06 |
368 |
ACTION POTENTIAL |
33 |
94 |
7.737e-07 |
9.782e-06 |
369 |
CALCIUM MEDIATED SIGNALING |
32 |
90 |
8.184e-07 |
1.032e-05 |
370 |
POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC |
12 |
18 |
8.316e-07 |
1.046e-05 |
371 |
REGULATION OF HEART RATE |
31 |
86 |
8.585e-07 |
1.077e-05 |
372 |
FEMALE SEX DIFFERENTIATION |
38 |
116 |
8.69e-07 |
1.087e-05 |
373 |
REGULATION OF PEPTIDE SECRETION |
58 |
209 |
8.771e-07 |
1.094e-05 |
374 |
REGULATION OF MUSCLE TISSUE DEVELOPMENT |
35 |
103 |
8.805e-07 |
1.095e-05 |
375 |
REGULATION OF DENDRITIC SPINE MORPHOGENESIS |
16 |
30 |
9.199e-07 |
1.141e-05 |
376 |
REGULATION OF INFLAMMATORY RESPONSE |
75 |
294 |
9.249e-07 |
1.145e-05 |
377 |
VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY |
28 |
74 |
9.306e-07 |
1.149e-05 |
378 |
NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS |
71 |
274 |
9.628e-07 |
1.185e-05 |
379 |
POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION |
48 |
162 |
9.873e-07 |
1.212e-05 |
380 |
POSITIVE REGULATION OF HEART GROWTH |
15 |
27 |
1.012e-06 |
1.234e-05 |
381 |
RESPONSE TO INORGANIC SUBSTANCE |
110 |
479 |
1.016e-06 |
1.234e-05 |
382 |
ARTERY MORPHOGENESIS |
22 |
51 |
1.01e-06 |
1.234e-05 |
383 |
SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION |
96 |
404 |
1.014e-06 |
1.234e-05 |
384 |
POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE |
50 |
172 |
1.11e-06 |
1.345e-05 |
385 |
DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS |
35 |
104 |
1.14e-06 |
1.378e-05 |
386 |
VESICLE MEDIATED TRANSPORT |
243 |
1239 |
1.147e-06 |
1.383e-05 |
387 |
REGULATION OF LEUKOCYTE MIGRATION |
45 |
149 |
1.191e-06 |
1.431e-05 |
388 |
SECRETION BY CELL |
111 |
486 |
1.201e-06 |
1.436e-05 |
389 |
REGULATION OF LIPASE ACTIVITY |
30 |
83 |
1.201e-06 |
1.436e-05 |
390 |
OVULATION CYCLE |
37 |
113 |
1.22e-06 |
1.455e-05 |
391 |
DENDRITE DEVELOPMENT |
29 |
79 |
1.245e-06 |
1.482e-05 |
392 |
REGULATION OF EPITHELIAL CELL DIFFERENTIATION |
39 |
122 |
1.259e-06 |
1.495e-05 |
393 |
SENSORY PERCEPTION OF PAIN |
28 |
75 |
1.277e-06 |
1.508e-05 |
394 |
REGULATION OF BIOMINERAL TISSUE DEVELOPMENT |
28 |
75 |
1.277e-06 |
1.508e-05 |
395 |
REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION |
26 |
67 |
1.286e-06 |
1.515e-05 |
396 |
REGULATION OF CANONICAL WNT SIGNALING PATHWAY |
63 |
236 |
1.31e-06 |
1.54e-05 |
397 |
REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE |
55 |
197 |
1.355e-06 |
1.588e-05 |
398 |
CAMP METABOLIC PROCESS |
17 |
34 |
1.381e-06 |
1.615e-05 |
399 |
POSITIVE REGULATION OF MAP KINASE ACTIVITY |
57 |
207 |
1.424e-06 |
1.66e-05 |
400 |
POSITIVE REGULATION OF SECRETION |
89 |
370 |
1.445e-06 |
1.681e-05 |
401 |
HEART MORPHOGENESIS |
58 |
212 |
1.452e-06 |
1.684e-05 |
402 |
NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION |
19 |
41 |
1.462e-06 |
1.692e-05 |
403 |
OVULATION CYCLE PROCESS |
31 |
88 |
1.521e-06 |
1.756e-05 |
404 |
POSITIVE REGULATION OF ENDOCYTOSIS |
37 |
114 |
1.551e-06 |
1.786e-05 |
405 |
POSITIVE REGULATION OF CELL ADHESION |
90 |
376 |
1.577e-06 |
1.812e-05 |
406 |
REGULATION OF DENDRITIC SPINE DEVELOPMENT |
23 |
56 |
1.636e-06 |
1.866e-05 |
407 |
SYSTEM PROCESS |
333 |
1785 |
1.629e-06 |
1.866e-05 |
408 |
POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT |
23 |
56 |
1.636e-06 |
1.866e-05 |
409 |
CHONDROCYTE DIFFERENTIATION |
24 |
60 |
1.725e-06 |
1.962e-05 |
410 |
POSITIVE REGULATION OF TRANSPORTER ACTIVITY |
28 |
76 |
1.738e-06 |
1.963e-05 |
411 |
RESPONSE TO ALKALOID |
42 |
137 |
1.73e-06 |
1.963e-05 |
412 |
CELLULAR RESPONSE TO STEROID HORMONE STIMULUS |
59 |
218 |
1.735e-06 |
1.963e-05 |
413 |
CELLULAR RESPONSE TO OXIDATIVE STRESS |
52 |
184 |
1.748e-06 |
1.97e-05 |
414 |
POSITIVE REGULATION OF DENDRITE DEVELOPMENT |
25 |
64 |
1.775e-06 |
1.995e-05 |
415 |
WNT SIGNALING PATHWAY |
85 |
351 |
1.848e-06 |
2.072e-05 |
416 |
POSITIVE REGULATION OF ORGAN GROWTH |
18 |
38 |
1.855e-06 |
2.075e-05 |
417 |
PLATELET ACTIVATION |
43 |
142 |
1.883e-06 |
2.097e-05 |
418 |
REGULATION OF FATTY ACID OXIDATION |
15 |
28 |
1.881e-06 |
2.097e-05 |
419 |
REGULATION OF ENDOCYTOSIS |
55 |
199 |
1.908e-06 |
2.118e-05 |
420 |
NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION |
57 |
209 |
1.984e-06 |
2.198e-05 |
421 |
REGULATION OF SMOOTH MUSCLE CELL MIGRATION |
21 |
49 |
2.018e-06 |
2.23e-05 |
422 |
CELLULAR RESPONSE TO EXTERNAL STIMULUS |
68 |
264 |
2.031e-06 |
2.24e-05 |
423 |
CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION |
13 |
22 |
2.106e-06 |
2.316e-05 |
424 |
EYE DEVELOPMENT |
80 |
326 |
2.128e-06 |
2.336e-05 |
425 |
TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY |
53 |
190 |
2.151e-06 |
2.354e-05 |
426 |
POSITIVE REGULATION OF CHEMOTAXIS |
38 |
120 |
2.219e-06 |
2.424e-05 |
427 |
NEGATIVE REGULATION OF NEURON DEATH |
49 |
171 |
2.229e-06 |
2.429e-05 |
428 |
RESPONSE TO INSULIN |
56 |
205 |
2.3e-06 |
2.501e-05 |
429 |
RAS PROTEIN SIGNAL TRANSDUCTION |
43 |
143 |
2.312e-06 |
2.508e-05 |
430 |
NEGATIVE REGULATION OF KINASE ACTIVITY |
65 |
250 |
2.401e-06 |
2.598e-05 |
431 |
REGULATION OF ORGAN GROWTH |
27 |
73 |
2.425e-06 |
2.618e-05 |
432 |
DIGESTIVE SYSTEM DEVELOPMENT |
44 |
148 |
2.483e-06 |
2.674e-05 |
433 |
REGULATION OF CIRCADIAN RHYTHM |
34 |
103 |
2.646e-06 |
2.836e-05 |
434 |
REGULATION OF MUSCLE ORGAN DEVELOPMENT |
34 |
103 |
2.646e-06 |
2.836e-05 |
435 |
REGULATION OF CELL SIZE |
49 |
172 |
2.675e-06 |
2.862e-05 |
436 |
REGULATION OF CHONDROCYTE DIFFERENTIATION |
20 |
46 |
2.686e-06 |
2.867e-05 |
437 |
VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY |
10 |
14 |
2.786e-06 |
2.946e-05 |
438 |
NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS |
38 |
121 |
2.778e-06 |
2.946e-05 |
439 |
MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL |
10 |
14 |
2.786e-06 |
2.946e-05 |
440 |
POSITIVE REGULATION OF FATTY ACID OXIDATION |
10 |
14 |
2.786e-06 |
2.946e-05 |
441 |
POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS |
30 |
86 |
2.815e-06 |
2.97e-05 |
442 |
SALIVARY GLAND DEVELOPMENT |
16 |
32 |
2.829e-06 |
2.972e-05 |
443 |
REGULATION OF ORGAN FORMATION |
16 |
32 |
2.829e-06 |
2.972e-05 |
444 |
RESPONSE TO KETONE |
51 |
182 |
2.871e-06 |
3.008e-05 |
445 |
POSITIVE REGULATION OF HEMOPOIESIS |
47 |
163 |
2.945e-06 |
3.073e-05 |
446 |
CELLULAR RESPONSE TO BIOTIC STIMULUS |
47 |
163 |
2.945e-06 |
3.073e-05 |
447 |
NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS |
41 |
135 |
2.979e-06 |
3.094e-05 |
448 |
CELL GROWTH |
41 |
135 |
2.979e-06 |
3.094e-05 |
449 |
REGULATION OF ADHERENS JUNCTION ORGANIZATION |
21 |
50 |
2.996e-06 |
3.105e-05 |
450 |
REGULATION OF LEUKOCYTE DIFFERENTIATION |
61 |
232 |
3.274e-06 |
3.386e-05 |
451 |
RESPONSE TO ACID CHEMICAL |
78 |
319 |
3.282e-06 |
3.386e-05 |
452 |
POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT |
15 |
29 |
3.362e-06 |
3.461e-05 |
453 |
NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS |
25 |
66 |
3.437e-06 |
3.507e-05 |
454 |
NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY |
25 |
66 |
3.437e-06 |
3.507e-05 |
455 |
REGULATION OF CARDIAC CONDUCTION |
25 |
66 |
3.437e-06 |
3.507e-05 |
456 |
POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING |
24 |
62 |
3.435e-06 |
3.507e-05 |
457 |
REGULATION OF CYTOSKELETON ORGANIZATION |
112 |
502 |
3.493e-06 |
3.557e-05 |
458 |
CEREBRAL CORTEX CELL MIGRATION |
19 |
43 |
3.551e-06 |
3.608e-05 |
459 |
REGULATION OF CELLULAR PROTEIN LOCALIZATION |
121 |
552 |
3.603e-06 |
3.653e-05 |
460 |
TISSUE REMODELING |
30 |
87 |
3.693e-06 |
3.735e-05 |
461 |
NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION |
17 |
36 |
3.783e-06 |
3.802e-05 |
462 |
CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT |
17 |
36 |
3.783e-06 |
3.802e-05 |
463 |
POSITIVE REGULATION OF GROWTH |
62 |
238 |
3.791e-06 |
3.802e-05 |
464 |
SEMAPHORIN PLEXIN SIGNALING PATHWAY |
17 |
36 |
3.783e-06 |
3.802e-05 |
465 |
MUSCLE CONTRACTION |
61 |
233 |
3.805e-06 |
3.807e-05 |
466 |
EXOCYTOSIS |
76 |
310 |
3.929e-06 |
3.923e-05 |
467 |
MYELOID CELL DIFFERENTIATION |
52 |
189 |
4.147e-06 |
4.132e-05 |
468 |
RESPONSE TO ESTRADIOL |
43 |
146 |
4.202e-06 |
4.16e-05 |
469 |
REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING |
13 |
23 |
4.186e-06 |
4.16e-05 |
470 |
REGULATION OF SYNAPSE ASSEMBLY |
28 |
79 |
4.195e-06 |
4.16e-05 |
471 |
EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING |
121 |
554 |
4.335e-06 |
4.282e-05 |
472 |
GLIOGENESIS |
49 |
175 |
4.56e-06 |
4.496e-05 |
473 |
NEURON RECOGNITION |
16 |
33 |
4.738e-06 |
4.661e-05 |
474 |
REGULATION OF CARTILAGE DEVELOPMENT |
24 |
63 |
4.775e-06 |
4.688e-05 |
475 |
EAR DEVELOPMENT |
53 |
195 |
4.979e-06 |
4.878e-05 |
476 |
INOSITOL LIPID MEDIATED SIGNALING |
38 |
124 |
5.333e-06 |
5.213e-05 |
477 |
REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS |
44 |
152 |
5.377e-06 |
5.245e-05 |
478 |
POSITIVE REGULATION OF CALCIUM ION TRANSPORT |
34 |
106 |
5.428e-06 |
5.283e-05 |
479 |
REGULATION OF LIPID METABOLIC PROCESS |
70 |
282 |
5.89e-06 |
5.722e-05 |
480 |
REGULATION OF LEUKOCYTE PROLIFERATION |
55 |
206 |
5.962e-06 |
5.78e-05 |
481 |
IMPORT INTO CELL |
17 |
37 |
6.036e-06 |
5.827e-05 |
482 |
NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS |
33 |
102 |
6.027e-06 |
5.827e-05 |
483 |
REGULATION OF CELL JUNCTION ASSEMBLY |
25 |
68 |
6.418e-06 |
6.183e-05 |
484 |
OUTFLOW TRACT MORPHOGENESIS |
22 |
56 |
6.558e-06 |
6.304e-05 |
485 |
POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION |
23 |
60 |
6.63e-06 |
6.36e-05 |
486 |
ION TRANSPORT |
242 |
1262 |
6.769e-06 |
6.481e-05 |
487 |
REGULATION OF SEQUESTERING OF CALCIUM ION |
34 |
107 |
6.836e-06 |
6.531e-05 |
488 |
DEVELOPMENTAL CELL GROWTH |
27 |
77 |
7.796e-06 |
7.418e-05 |
489 |
SINGLE ORGANISM CELLULAR LOCALIZATION |
180 |
898 |
7.782e-06 |
7.418e-05 |
490 |
EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT |
13 |
24 |
7.893e-06 |
7.496e-05 |
491 |
DEVELOPMENTAL MATURATION |
52 |
193 |
7.984e-06 |
7.566e-05 |
492 |
REGULATION OF WOUND HEALING |
38 |
126 |
8.094e-06 |
7.642e-05 |
493 |
REGULATION OF JNK CASCADE |
45 |
159 |
8.097e-06 |
7.642e-05 |
494 |
REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION |
56 |
213 |
8.13e-06 |
7.657e-05 |
495 |
REGULATION OF CELLULAR RESPONSE TO STRESS |
144 |
691 |
8.171e-06 |
7.68e-05 |
496 |
CELLULAR RESPONSE TO CYTOKINE STIMULUS |
129 |
606 |
8.202e-06 |
7.695e-05 |
497 |
NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
36 |
117 |
8.428e-06 |
7.874e-05 |
498 |
MAMMARY GLAND DEVELOPMENT |
36 |
117 |
8.428e-06 |
7.874e-05 |
499 |
REGULATION OF CELL GROWTH |
90 |
391 |
8.595e-06 |
8.015e-05 |
500 |
REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT |
23 |
61 |
9.161e-06 |
8.525e-05 |
501 |
REGULATION OF CELL PROJECTION ASSEMBLY |
44 |
155 |
9.337e-06 |
8.671e-05 |
502 |
COLLAGEN FIBRIL ORGANIZATION |
17 |
38 |
9.42e-06 |
8.714e-05 |
503 |
POSITIVE REGULATION OF POTASSIUM ION TRANSPORT |
17 |
38 |
9.42e-06 |
8.714e-05 |
504 |
REGULATION OF CYTOKINE PRODUCTION |
121 |
563 |
9.713e-06 |
8.968e-05 |
505 |
POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION |
48 |
175 |
1.044e-05 |
9.621e-05 |
506 |
NEGATIVE REGULATION OF MOLECULAR FUNCTION |
210 |
1079 |
1.057e-05 |
9.721e-05 |
507 |
CELLULAR MACROMOLECULE LOCALIZATION |
236 |
1234 |
1.071e-05 |
9.827e-05 |
508 |
PROTEIN LOCALIZATION TO CELL PERIPHERY |
43 |
151 |
1.076e-05 |
9.856e-05 |
509 |
REGULATION OF HEART GROWTH |
18 |
42 |
1.079e-05 |
9.866e-05 |
510 |
CIRCADIAN RHYTHM |
40 |
137 |
1.126e-05 |
0.0001027 |
511 |
REGENERATION |
45 |
161 |
1.152e-05 |
0.0001049 |
512 |
REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY |
25 |
70 |
1.159e-05 |
0.0001053 |
513 |
CYCLIC NUCLEOTIDE MEDIATED SIGNALING |
19 |
46 |
1.18e-05 |
0.000107 |
514 |
RIBONUCLEOTIDE CATABOLIC PROCESS |
14 |
28 |
1.193e-05 |
0.0001078 |
515 |
REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION |
14 |
28 |
1.193e-05 |
0.0001078 |
516 |
POSITIVE REGULATION OF LIPASE ACTIVITY |
24 |
66 |
1.213e-05 |
0.0001092 |
517 |
REGULATION OF CARDIAC MUSCLE CONTRACTION |
24 |
66 |
1.213e-05 |
0.0001092 |
518 |
RESPONSE TO MONOAMINE |
16 |
35 |
1.228e-05 |
0.0001103 |
519 |
POSITIVE REGULATION OF HOMEOSTATIC PROCESS |
56 |
216 |
1.27e-05 |
0.0001138 |
520 |
REPRODUCTION |
246 |
1297 |
1.273e-05 |
0.0001139 |
521 |
REGULATION OF BINDING |
69 |
283 |
1.304e-05 |
0.0001164 |
522 |
POSITIVE REGULATION OF SYNAPTIC TRANSMISSION |
34 |
110 |
1.332e-05 |
0.0001187 |
523 |
MEMBRANE ASSEMBLY |
13 |
25 |
1.422e-05 |
0.0001262 |
524 |
REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY SARCOPLASMIC RETICULUM |
13 |
25 |
1.422e-05 |
0.0001262 |
525 |
LYMPHOCYTE ACTIVATION |
80 |
342 |
1.441e-05 |
0.0001271 |
526 |
REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL |
26 |
75 |
1.443e-05 |
0.0001271 |
527 |
POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION |
17 |
39 |
1.44e-05 |
0.0001271 |
528 |
NEURAL CREST CELL DIFFERENTIATION |
26 |
75 |
1.443e-05 |
0.0001271 |
529 |
CELLULAR RESPONSE TO ALCOHOL |
35 |
115 |
1.456e-05 |
0.0001281 |
530 |
PEPTIDYL SERINE MODIFICATION |
42 |
148 |
1.486e-05 |
0.0001305 |
531 |
DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION |
127 |
602 |
1.51e-05 |
0.0001323 |
532 |
NEGATIVE REGULATION OF LEUKOCYTE MIGRATION |
15 |
32 |
1.578e-05 |
0.000138 |
533 |
TISSUE MIGRATION |
28 |
84 |
1.595e-05 |
0.0001392 |
534 |
NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION |
18 |
43 |
1.601e-05 |
0.0001395 |
535 |
CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS |
12 |
22 |
1.621e-05 |
0.000141 |
536 |
RESPONSE TO ORGANOPHOSPHORUS |
40 |
139 |
1.641e-05 |
0.0001425 |
537 |
NEPHRON EPITHELIUM DEVELOPMENT |
30 |
93 |
1.673e-05 |
0.0001448 |
538 |
POSITIVE REGULATION OF ACTIN NUCLEATION |
10 |
16 |
1.674e-05 |
0.0001448 |
539 |
REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY |
84 |
365 |
1.702e-05 |
0.0001469 |
540 |
CARDIAC CHAMBER DEVELOPMENT |
41 |
144 |
1.713e-05 |
0.0001471 |
541 |
REGULATION OF JAK STAT CASCADE |
41 |
144 |
1.713e-05 |
0.0001471 |
542 |
REGULATION OF STAT CASCADE |
41 |
144 |
1.713e-05 |
0.0001471 |
543 |
REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION |
11 |
19 |
1.733e-05 |
0.0001482 |
544 |
GLOMERULAR EPITHELIUM DEVELOPMENT |
11 |
19 |
1.733e-05 |
0.0001482 |
545 |
VASCULOGENESIS |
22 |
59 |
1.752e-05 |
0.0001496 |
546 |
POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION |
111 |
514 |
1.795e-05 |
0.000153 |
547 |
NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION |
141 |
684 |
1.799e-05 |
0.0001531 |
548 |
POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT |
36 |
121 |
1.927e-05 |
0.0001633 |
549 |
REGULATION OF PROTEIN KINASE B SIGNALING |
36 |
121 |
1.927e-05 |
0.0001633 |
550 |
REGULATION OF BLOOD PRESSURE |
46 |
169 |
1.956e-05 |
0.0001654 |
551 |
CARDIAC MUSCLE CELL CONTRACTION |
14 |
29 |
1.993e-05 |
0.000168 |
552 |
REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC |
14 |
29 |
1.993e-05 |
0.000168 |
553 |
REGULATION OF AMINE TRANSPORT |
25 |
72 |
2.03e-05 |
0.0001708 |
554 |
NEGATIVE REGULATION OF MAPK CASCADE |
41 |
145 |
2.051e-05 |
0.0001721 |
555 |
NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY |
37 |
126 |
2.052e-05 |
0.0001721 |
556 |
POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION |
27 |
81 |
2.246e-05 |
0.0001879 |
557 |
REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION |
33 |
108 |
2.308e-05 |
0.0001928 |
558 |
NEGATIVE REGULATION OF SECRETION |
52 |
200 |
2.339e-05 |
0.0001951 |
559 |
PROTEIN DEPHOSPHORYLATION |
50 |
190 |
2.354e-05 |
0.0001959 |
560 |
POSITIVE REGULATION OF CELL SUBSTRATE ADHESION |
31 |
99 |
2.366e-05 |
0.0001966 |
561 |
REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT |
19 |
48 |
2.435e-05 |
0.000202 |
562 |
NEGATIVE REGULATION OF ION TRANSPORT |
37 |
127 |
2.488e-05 |
0.000206 |
563 |
NEGATIVE REGULATION OF RESPONSE TO WOUNDING |
43 |
156 |
2.583e-05 |
0.0002134 |
564 |
CARDIAC CHAMBER MORPHOGENESIS |
32 |
104 |
2.612e-05 |
0.0002147 |
565 |
POSITIVE REGULATION OF PROTEIN IMPORT |
32 |
104 |
2.612e-05 |
0.0002147 |
566 |
CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES |
32 |
104 |
2.612e-05 |
0.0002147 |
567 |
POSITIVE REGULATION OF STAT CASCADE |
25 |
73 |
2.657e-05 |
0.0002173 |
568 |
POSITIVE REGULATION OF PROTEIN SECRETION |
54 |
211 |
2.657e-05 |
0.0002173 |
569 |
POSITIVE REGULATION OF JAK STAT CASCADE |
25 |
73 |
2.657e-05 |
0.0002173 |
570 |
SYNAPTIC SIGNALING |
94 |
424 |
2.681e-05 |
0.0002189 |
571 |
INTEGRIN MEDIATED SIGNALING PATHWAY |
27 |
82 |
2.881e-05 |
0.0002347 |
572 |
EMBRYONIC ORGAN MORPHOGENESIS |
67 |
279 |
2.896e-05 |
0.0002351 |
573 |
POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT3 PROTEIN |
16 |
37 |
2.9e-05 |
0.0002351 |
574 |
AXON EXTENSION |
16 |
37 |
2.9e-05 |
0.0002351 |
575 |
POSITIVE REGULATION OF VASCULATURE DEVELOPMENT |
38 |
133 |
3.145e-05 |
0.0002545 |
576 |
CELL SUBSTRATE JUNCTION ASSEMBLY |
17 |
41 |
3.185e-05 |
0.0002573 |
577 |
POSITIVE REGULATION OF STEM CELL PROLIFERATION |
22 |
61 |
3.209e-05 |
0.0002588 |
578 |
MEMBRANE BIOGENESIS |
14 |
30 |
3.229e-05 |
0.0002591 |
579 |
NEGATIVE REGULATION OF CELL MATRIX ADHESION |
14 |
30 |
3.229e-05 |
0.0002591 |
580 |
POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION |
14 |
30 |
3.229e-05 |
0.0002591 |
581 |
CAMP CATABOLIC PROCESS |
9 |
14 |
3.299e-05 |
0.0002642 |
582 |
PARTURITION |
11 |
20 |
3.335e-05 |
0.0002662 |
583 |
AXONAL FASCICULATION |
11 |
20 |
3.335e-05 |
0.0002662 |
584 |
SKELETAL MUSCLE CELL DIFFERENTIATION |
20 |
53 |
3.417e-05 |
0.0002722 |
585 |
CYCLIC NUCLEOTIDE CATABOLIC PROCESS |
10 |
17 |
3.525e-05 |
0.0002804 |
586 |
NEGATIVE REGULATION OF CELL CYCLE |
95 |
433 |
3.728e-05 |
0.000296 |
587 |
PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY |
15 |
34 |
3.861e-05 |
0.000305 |
588 |
FOREBRAIN NEURON DEVELOPMENT |
15 |
34 |
3.861e-05 |
0.000305 |
589 |
RESPONSE TO FLUID SHEAR STRESS |
15 |
34 |
3.861e-05 |
0.000305 |
590 |
REGULATION OF VASOCONSTRICTION |
23 |
66 |
4.025e-05 |
0.0003174 |
591 |
SEX DIFFERENTIATION |
64 |
266 |
4.061e-05 |
0.0003197 |
592 |
REGULATION OF CATENIN IMPORT INTO NUCLEUS |
13 |
27 |
4.099e-05 |
0.0003217 |
593 |
CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS |
13 |
27 |
4.099e-05 |
0.0003217 |
594 |
REGULATION OF VESICLE MEDIATED TRANSPORT |
100 |
462 |
4.162e-05 |
0.000326 |
595 |
REGULATION OF STEM CELL PROLIFERATION |
28 |
88 |
4.176e-05 |
0.0003266 |
596 |
NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION |
22 |
62 |
4.285e-05 |
0.0003345 |
597 |
REGULATION OF RENAL SYSTEM PROCESS |
16 |
38 |
4.324e-05 |
0.0003365 |
598 |
ACTIN FILAMENT ORGANIZATION |
46 |
174 |
4.325e-05 |
0.0003365 |
599 |
REGULATION OF CELL CELL ADHESION |
85 |
380 |
4.56e-05 |
0.0003542 |
600 |
REGULATION OF CELL CYCLE |
184 |
949 |
4.65e-05 |
0.0003606 |
601 |
POSITIVE REGULATION OF STEM CELL DIFFERENTIATION |
19 |
50 |
4.769e-05 |
0.0003692 |
602 |
NEGATIVE REGULATION OF IMMUNE RESPONSE |
35 |
121 |
4.795e-05 |
0.0003707 |
603 |
NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT |
24 |
71 |
4.869e-05 |
0.0003757 |
604 |
PLATELET DEGRANULATION |
32 |
107 |
4.879e-05 |
0.0003758 |
605 |
PHAGOCYTOSIS |
49 |
190 |
4.962e-05 |
0.0003816 |
606 |
ENDOCYTOSIS |
108 |
509 |
5e-05 |
0.0003839 |
607 |
OSTEOBLAST DIFFERENTIATION |
36 |
126 |
5.017e-05 |
0.0003845 |
608 |
HOMEOSTASIS OF NUMBER OF CELLS |
46 |
175 |
5.038e-05 |
0.0003856 |
609 |
BLOOD VESSEL ENDOTHELIAL CELL MIGRATION |
12 |
24 |
5.076e-05 |
0.0003878 |
610 |
ADULT LOCOMOTORY BEHAVIOR |
26 |
80 |
5.174e-05 |
0.0003947 |
611 |
DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS |
54 |
216 |
5.295e-05 |
0.0004032 |
612 |
ENDOMEMBRANE SYSTEM ORGANIZATION |
100 |
465 |
5.431e-05 |
0.0004129 |
613 |
REGULATION OF RECEPTOR ACTIVITY |
34 |
117 |
5.511e-05 |
0.0004183 |
614 |
REGULATION OF CALCIUM ION IMPORT |
31 |
103 |
5.56e-05 |
0.0004213 |
615 |
SKELETAL SYSTEM MORPHOGENESIS |
51 |
201 |
5.583e-05 |
0.0004224 |
616 |
CELL FATE COMMITMENT |
56 |
227 |
5.777e-05 |
0.0004364 |
617 |
HEART PROCESS |
27 |
85 |
5.874e-05 |
0.000443 |
618 |
LIPID LOCALIZATION |
63 |
264 |
6.017e-05 |
0.0004531 |
619 |
POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT |
21 |
59 |
6.032e-05 |
0.0004535 |
620 |
REGULATION OF HOMOTYPIC CELL CELL ADHESION |
71 |
307 |
6.248e-05 |
0.0004682 |
621 |
REGULATION OF PROTEIN TARGETING |
71 |
307 |
6.248e-05 |
0.0004682 |
622 |
MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL |
16 |
39 |
6.33e-05 |
0.0004732 |
623 |
CRANIAL SKELETAL SYSTEM DEVELOPMENT |
20 |
55 |
6.336e-05 |
0.0004732 |
624 |
NEURAL CREST CELL MIGRATION |
19 |
51 |
6.553e-05 |
0.0004875 |
625 |
NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING |
19 |
51 |
6.553e-05 |
0.0004875 |
626 |
POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING |
26 |
81 |
6.559e-05 |
0.0004875 |
627 |
MUSCLE HYPERTROPHY |
13 |
28 |
6.618e-05 |
0.0004903 |
628 |
POSITIVE REGULATION OF PHOSPHATASE ACTIVITY |
13 |
28 |
6.618e-05 |
0.0004903 |
629 |
NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY |
18 |
47 |
6.651e-05 |
0.000492 |
630 |
POSITIVE REGULATION OF RESPONSE TO WOUNDING |
43 |
162 |
6.826e-05 |
0.0005042 |
631 |
OVULATION |
10 |
18 |
6.877e-05 |
0.0005063 |
632 |
ORGAN GROWTH |
23 |
68 |
6.87e-05 |
0.0005063 |
633 |
CATION TRANSPORT |
157 |
796 |
6.93e-05 |
0.0005094 |
634 |
SENSORY ORGAN MORPHOGENESIS |
58 |
239 |
7.055e-05 |
0.0005178 |
635 |
CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS |
9 |
15 |
7.161e-05 |
0.0005231 |
636 |
REGULATION OF HEAT GENERATION |
9 |
15 |
7.161e-05 |
0.0005231 |
637 |
NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION |
9 |
15 |
7.161e-05 |
0.0005231 |
638 |
REGULATION OF SODIUM ION TRANSPORT |
25 |
77 |
7.292e-05 |
0.000531 |
639 |
ACTOMYOSIN STRUCTURE ORGANIZATION |
25 |
77 |
7.292e-05 |
0.000531 |
640 |
NEGATIVE REGULATION OF CELL CELL ADHESION |
38 |
138 |
7.583e-05 |
0.0005513 |
641 |
NEGATIVE REGULATION OF INFLAMMATORY RESPONSE |
30 |
100 |
7.771e-05 |
0.0005641 |
642 |
NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT |
14 |
32 |
7.82e-05 |
0.0005668 |
643 |
HORMONE MEDIATED SIGNALING PATHWAY |
42 |
158 |
7.948e-05 |
0.0005742 |
644 |
NEGATIVE REGULATION OF CELL ACTIVATION |
42 |
158 |
7.948e-05 |
0.0005742 |
645 |
REGULATION OF GLUCOSE IMPORT |
21 |
60 |
7.998e-05 |
0.000577 |
646 |
LYMPHOCYTE DIFFERENTIATION |
52 |
209 |
8.239e-05 |
0.0005934 |
647 |
POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION |
12 |
25 |
8.45e-05 |
0.0006077 |
648 |
POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS |
36 |
129 |
8.577e-05 |
0.0006159 |
649 |
POSITIVE REGULATION OF AXON EXTENSION |
15 |
36 |
8.643e-05 |
0.0006178 |
650 |
NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY |
15 |
36 |
8.643e-05 |
0.0006178 |
651 |
POSITIVE CHEMOTAXIS |
15 |
36 |
8.643e-05 |
0.0006178 |
652 |
MYELOID LEUKOCYTE DIFFERENTIATION |
29 |
96 |
8.852e-05 |
0.0006317 |
653 |
POSITIVE REGULATION OF AXONOGENESIS |
23 |
69 |
8.875e-05 |
0.0006324 |
654 |
REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY |
16 |
40 |
9.109e-05 |
0.0006461 |
655 |
FORELIMB MORPHOGENESIS |
16 |
40 |
9.109e-05 |
0.0006461 |
656 |
NEGATIVE REGULATION OF DEFENSE RESPONSE |
39 |
144 |
9.101e-05 |
0.0006461 |
657 |
REGULATION OF MYOBLAST DIFFERENTIATION |
18 |
48 |
9.18e-05 |
0.0006501 |
658 |
NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION |
33 |
115 |
9.231e-05 |
0.0006518 |
659 |
RESPONSE TO INTERLEUKIN 1 |
33 |
115 |
9.231e-05 |
0.0006518 |
660 |
CELL CYCLE ARREST |
41 |
154 |
9.253e-05 |
0.0006524 |
661 |
POSITIVE REGULATION OF MUSCLE CONTRACTION |
17 |
44 |
9.268e-05 |
0.0006524 |
662 |
REGULATION OF EXTENT OF CELL GROWTH |
30 |
101 |
9.509e-05 |
0.0006684 |
663 |
REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS |
22 |
65 |
9.698e-05 |
0.0006806 |
664 |
STEROID HORMONE MEDIATED SIGNALING PATHWAY |
35 |
125 |
9.929e-05 |
0.0006957 |
665 |
IMMUNE RESPONSE |
207 |
1100 |
0.0001009 |
0.0007059 |
666 |
ACTIN MEDIATED CELL CONTRACTION |
24 |
74 |
0.0001028 |
0.0007184 |
667 |
REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION |
13 |
29 |
0.0001038 |
0.0007227 |
668 |
CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION |
13 |
29 |
0.0001038 |
0.0007227 |
669 |
POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE |
37 |
135 |
0.0001041 |
0.0007241 |
670 |
NEGATIVE REGULATION OF MUSCLE CONTRACTION |
11 |
22 |
0.0001051 |
0.0007291 |
671 |
POSITIVE REGULATION OF SYNAPSE ASSEMBLY |
21 |
61 |
0.0001051 |
0.0007291 |
672 |
COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION |
32 |
111 |
0.0001063 |
0.0007361 |
673 |
NEGATIVE REGULATION OF CYTOKINE PRODUCTION |
52 |
211 |
0.0001071 |
0.0007404 |
674 |
SENSORY PERCEPTION OF MECHANICAL STIMULUS |
41 |
155 |
0.0001081 |
0.0007462 |
675 |
METAL ION TRANSPORT |
119 |
582 |
0.000113 |
0.0007775 |
676 |
ENDOTHELIAL CELL MIGRATION |
20 |
57 |
0.0001128 |
0.0007775 |
677 |
NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION |
30 |
102 |
0.0001159 |
0.0007965 |
678 |
REGULATION OF LEUKOCYTE APOPTOTIC PROCESS |
25 |
79 |
0.0001164 |
0.0007976 |
679 |
REGULATION OF STRIATED MUSCLE CONTRACTION |
25 |
79 |
0.0001164 |
0.0007976 |
680 |
POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS |
14 |
33 |
0.0001174 |
0.0008022 |
681 |
REGULATION OF CELL AGING |
14 |
33 |
0.0001174 |
0.0008022 |
682 |
NEURON PROJECTION EXTENSION |
19 |
53 |
0.0001197 |
0.0008156 |
683 |
CELLULAR RESPONSE TO AMINO ACID STIMULUS |
19 |
53 |
0.0001197 |
0.0008156 |
684 |
REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING |
56 |
233 |
0.0001227 |
0.0008344 |
685 |
CYTOKINE MEDIATED SIGNALING PATHWAY |
96 |
452 |
0.0001229 |
0.0008347 |
686 |
CORONARY VASCULATURE DEVELOPMENT |
15 |
37 |
0.0001256 |
0.0008506 |
687 |
HINDLIMB MORPHOGENESIS |
15 |
37 |
0.0001256 |
0.0008506 |
688 |
POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION |
10 |
19 |
0.0001259 |
0.0008517 |
689 |
EXOCRINE SYSTEM DEVELOPMENT |
17 |
45 |
0.0001286 |
0.0008682 |
690 |
POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION |
26 |
84 |
0.0001292 |
0.0008686 |
691 |
NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH |
26 |
84 |
0.0001292 |
0.0008686 |
692 |
AORTA DEVELOPMENT |
16 |
41 |
0.000129 |
0.0008686 |
693 |
CALCIUM ION TRANSPORT |
54 |
223 |
0.0001306 |
0.0008766 |
694 |
LEUKOCYTE CHEMOTAXIS |
33 |
117 |
0.0001329 |
0.0008895 |
695 |
NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION |
29 |
98 |
0.0001328 |
0.0008895 |
696 |
REGULATION OF CELLULAR SENESCENCE |
12 |
26 |
0.0001359 |
0.0009082 |
697 |
NEGATIVE REGULATION OF ADHERENS JUNCTION ORGANIZATION |
9 |
16 |
0.0001422 |
0.0009463 |
698 |
NEURON CELL CELL ADHESION |
9 |
16 |
0.0001422 |
0.0009463 |
699 |
RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE |
9 |
16 |
0.0001422 |
0.0009463 |
700 |
REGULATION OF INTRACELLULAR PROTEIN TRANSPORT |
83 |
381 |
0.0001437 |
0.0009552 |
701 |
REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NEUROLOGICAL SYSTEM PROCESS |
8 |
13 |
0.0001451 |
0.0009633 |
702 |
REGULATION OF CELL CYCLE G1 S PHASE TRANSITION |
39 |
147 |
0.0001467 |
0.0009719 |
703 |
POSITIVE REGULATION OF WNT SIGNALING PATHWAY |
40 |
152 |
0.0001468 |
0.0009719 |
704 |
CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS |
47 |
188 |
0.0001562 |
0.001032 |
705 |
NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS |
13 |
30 |
0.0001584 |
0.001038 |
706 |
POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION |
13 |
30 |
0.0001584 |
0.001038 |
707 |
BROWN FAT CELL DIFFERENTIATION |
13 |
30 |
0.0001584 |
0.001038 |
708 |
MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL |
13 |
30 |
0.0001584 |
0.001038 |
709 |
REGULATION OF HEART RATE BY CARDIAC CONDUCTION |
13 |
30 |
0.0001584 |
0.001038 |
710 |
REGULATION OF MEMBRANE REPOLARIZATION |
13 |
30 |
0.0001584 |
0.001038 |
711 |
PALATE DEVELOPMENT |
26 |
85 |
0.0001602 |
0.001049 |
712 |
LIPID PHOSPHORYLATION |
29 |
99 |
0.0001615 |
0.001056 |
713 |
T CELL DIFFERENTIATION |
34 |
123 |
0.0001627 |
0.001062 |
714 |
EXTRACELLULAR MATRIX DISASSEMBLY |
24 |
76 |
0.0001639 |
0.001068 |
715 |
POSITIVE REGULATION OF LIPID METABOLIC PROCESS |
35 |
128 |
0.000166 |
0.001078 |
716 |
CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES |
50 |
204 |
0.0001659 |
0.001078 |
717 |
PURINE CONTAINING COMPOUND CATABOLIC PROCESS |
18 |
50 |
0.0001688 |
0.001094 |
718 |
VASCULAR PROCESS IN CIRCULATORY SYSTEM |
42 |
163 |
0.0001686 |
0.001094 |
719 |
RESPONSE TO METAL ION |
74 |
333 |
0.0001697 |
0.001098 |
720 |
RESPONSE TO CAMP |
30 |
104 |
0.0001701 |
0.001099 |
721 |
NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT |
38 |
143 |
0.0001709 |
0.001103 |
722 |
POSITIVE REGULATION OF SODIUM ION TRANSPORT |
14 |
34 |
0.0001726 |
0.001111 |
723 |
RENAL WATER HOMEOSTASIS |
14 |
34 |
0.0001726 |
0.001111 |
724 |
MESONEPHROS DEVELOPMENT |
27 |
90 |
0.0001734 |
0.001115 |
725 |
REGULATION OF METANEPHROS DEVELOPMENT |
11 |
23 |
0.0001746 |
0.001119 |
726 |
DIVALENT INORGANIC CATION TRANSPORT |
62 |
268 |
0.0001746 |
0.001119 |
727 |
EMBRYONIC CRANIAL SKELETON MORPHOGENESIS |
17 |
46 |
0.000176 |
0.001127 |
728 |
POSITIVE REGULATION OF LEUKOCYTE MIGRATION |
31 |
109 |
0.0001774 |
0.001132 |
729 |
RESPONSE TO HYDROGEN PEROXIDE |
31 |
109 |
0.0001774 |
0.001132 |
730 |
BONE MINERALIZATION |
15 |
38 |
0.0001793 |
0.00114 |
731 |
POSITIVE REGULATION OF BIOMINERAL TISSUE DEVELOPMENT |
15 |
38 |
0.0001793 |
0.00114 |
732 |
REGULATION OF ACTION POTENTIAL |
15 |
38 |
0.0001793 |
0.00114 |
733 |
DENDRITE MORPHOGENESIS |
16 |
42 |
0.00018 |
0.001142 |
734 |
METANEPHROS DEVELOPMENT |
25 |
81 |
0.0001816 |
0.001149 |
735 |
PEPTIDYL AMINO ACID MODIFICATION |
162 |
841 |
0.0001815 |
0.001149 |
736 |
REGULATION OF ORGANELLE ORGANIZATION |
218 |
1178 |
0.0001829 |
0.001156 |
737 |
REGULATION OF EMBRYONIC DEVELOPMENT |
32 |
114 |
0.0001836 |
0.001159 |
738 |
NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT |
28 |
95 |
0.0001853 |
0.001168 |
739 |
RESPONSE TO EXTRACELLULAR STIMULUS |
93 |
441 |
0.000202 |
0.001272 |
740 |
REGULATION OF NEUROTRANSMITTER LEVELS |
47 |
190 |
0.0002038 |
0.001281 |
741 |
ODONTOGENESIS |
30 |
105 |
0.0002049 |
0.001286 |
742 |
REGULATION OF KIDNEY DEVELOPMENT |
19 |
55 |
0.00021 |
0.001315 |
743 |
REGULATION OF B CELL PROLIFERATION |
19 |
55 |
0.00021 |
0.001315 |
744 |
FORMATION OF PRIMARY GERM LAYER |
31 |
110 |
0.0002125 |
0.001326 |
745 |
ENSHEATHMENT OF NEURONS |
27 |
91 |
0.0002123 |
0.001326 |
746 |
AXON ENSHEATHMENT |
27 |
91 |
0.0002123 |
0.001326 |
747 |
NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY |
10 |
20 |
0.0002185 |
0.001361 |
748 |
NEGATIVE REGULATION OF CELL GROWTH |
43 |
170 |
0.000221 |
0.001375 |
749 |
REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION |
18 |
51 |
0.0002251 |
0.001397 |
750 |
RESPONSE TO NICOTINE |
18 |
51 |
0.0002251 |
0.001397 |
751 |
NEGATIVE REGULATION OF MAP KINASE ACTIVITY |
23 |
73 |
0.0002311 |
0.00143 |
752 |
CELLULAR RESPONSE TO KETONE |
23 |
73 |
0.0002311 |
0.00143 |
753 |
INFLAMMATORY RESPONSE |
95 |
454 |
0.0002314 |
0.00143 |
754 |
MEMBRANE ORGANIZATION |
171 |
899 |
0.0002331 |
0.001439 |
755 |
GLYCOPROTEIN METABOLIC PROCESS |
77 |
353 |
0.0002347 |
0.001447 |
756 |
ESTABLISHMENT OF PROTEIN LOCALIZATION |
257 |
1423 |
0.0002469 |
0.001519 |
757 |
CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS |
16 |
43 |
0.0002476 |
0.001522 |
758 |
REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION |
20 |
60 |
0.0002506 |
0.001538 |
759 |
REGULATION OF AXON GUIDANCE |
15 |
39 |
0.0002518 |
0.001542 |
760 |
LONG TERM SYNAPTIC POTENTIATION |
15 |
39 |
0.0002518 |
0.001542 |
761 |
NEGATIVE REGULATION OF OSSIFICATION |
22 |
69 |
0.0002592 |
0.001585 |
762 |
REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS |
9 |
17 |
0.0002624 |
0.0016 |
763 |
REGULATION OF PRI MIRNA TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
9 |
17 |
0.0002624 |
0.0016 |
764 |
PROTEIN AUTOPHOSPHORYLATION |
47 |
192 |
0.000264 |
0.001608 |
765 |
RESPONSE TO ETHANOL |
36 |
136 |
0.0002713 |
0.00165 |
766 |
PROTEOGLYCAN METABOLIC PROCESS |
25 |
83 |
0.0002772 |
0.001684 |
767 |
FOCAL ADHESION ASSEMBLY |
11 |
24 |
0.0002794 |
0.001689 |
768 |
REGULATION OF POSITIVE CHEMOTAXIS |
11 |
24 |
0.0002794 |
0.001689 |
769 |
POSITIVE REGULATION OF RECEPTOR INTERNALIZATION |
11 |
24 |
0.0002794 |
0.001689 |
770 |
CELL SUBSTRATE ADHERENS JUNCTION ASSEMBLY |
11 |
24 |
0.0002794 |
0.001689 |
771 |
CELLULAR RESPONSE TO RETINOIC ACID |
21 |
65 |
0.0002895 |
0.001747 |
772 |
IN UTERO EMBRYONIC DEVELOPMENT |
69 |
311 |
0.0002898 |
0.001747 |
773 |
POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS |
7 |
11 |
0.0002926 |
0.001759 |
774 |
REGULATION OF FEVER GENERATION |
7 |
11 |
0.0002926 |
0.001759 |
775 |
RESPONSE TO RETINOIC ACID |
30 |
107 |
0.0002939 |
0.001765 |
776 |
CRANIOFACIAL SUTURE MORPHOGENESIS |
8 |
14 |
0.0002946 |
0.001767 |
777 |
REGULATION OF COAGULATION |
26 |
88 |
0.0002968 |
0.001775 |
778 |
REGULATION OF LIPID CATABOLIC PROCESS |
18 |
52 |
0.0002971 |
0.001775 |
779 |
REGULATION OF CATION CHANNEL ACTIVITY |
26 |
88 |
0.0002968 |
0.001775 |
780 |
NEGATIVE REGULATION OF CYTOPLASMIC TRANSPORT |
32 |
117 |
0.0003078 |
0.001836 |
781 |
POSITIVE REGULATION OF BINDING |
34 |
127 |
0.0003149 |
0.001876 |
782 |
HINDBRAIN DEVELOPMENT |
36 |
137 |
0.0003164 |
0.001882 |
783 |
POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS |
17 |
48 |
0.0003183 |
0.001887 |
784 |
REGULATION OF LIPID KINASE ACTIVITY |
17 |
48 |
0.0003183 |
0.001887 |
785 |
POSITIVE REGULATION OF WOUND HEALING |
17 |
48 |
0.0003183 |
0.001887 |
786 |
NEGATIVE REGULATION OF DENDRITE DEVELOPMENT |
12 |
28 |
0.0003209 |
0.0019 |
787 |
REGULATION OF TYROSINE PHOSPHORYLATION OF STAT3 PROTEIN |
16 |
44 |
0.0003361 |
0.001987 |
788 |
REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE |
25 |
84 |
0.00034 |
0.002007 |
789 |
ION TRANSMEMBRANE TRANSPORT |
157 |
822 |
0.0003411 |
0.002012 |
790 |
REGULATION OF IMMUNE RESPONSE |
163 |
858 |
0.0003437 |
0.002024 |
791 |
ENDODERMAL CELL DIFFERENTIATION |
15 |
40 |
0.0003482 |
0.002048 |
792 |
MUCOPOLYSACCHARIDE METABOLIC PROCESS |
30 |
108 |
0.0003502 |
0.002058 |
793 |
REGULATION OF ERYTHROCYTE DIFFERENTIATION |
14 |
36 |
0.000352 |
0.002065 |
794 |
CIRCADIAN REGULATION OF GENE EXPRESSION |
19 |
57 |
0.0003548 |
0.002079 |
795 |
HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES |
39 |
153 |
0.0003577 |
0.002093 |
796 |
POSITIVE REGULATION OF AUTOPHAGY |
23 |
75 |
0.0003591 |
0.002096 |
797 |
MULTI ORGANISM BEHAVIOR |
23 |
75 |
0.0003591 |
0.002096 |
798 |
SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT |
10 |
21 |
0.000362 |
0.002106 |
799 |
LIPID TRANSLOCATION |
10 |
21 |
0.000362 |
0.002106 |
800 |
POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL |
10 |
21 |
0.000362 |
0.002106 |
801 |
FOREBRAIN GENERATION OF NEURONS |
21 |
66 |
0.0003661 |
0.002124 |
802 |
LENS DEVELOPMENT IN CAMERA TYPE EYE |
21 |
66 |
0.0003661 |
0.002124 |
803 |
PLACENTA DEVELOPMENT |
36 |
138 |
0.000368 |
0.002133 |
804 |
MAMMARY GLAND EPITHELIUM DEVELOPMENT |
18 |
53 |
0.0003884 |
0.002244 |
805 |
REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY |
18 |
53 |
0.0003884 |
0.002244 |
806 |
CELLULAR RESPONSE TO MECHANICAL STIMULUS |
24 |
80 |
0.0003888 |
0.002244 |
807 |
REGULATION OF NUCLEOTIDE METABOLIC PROCESS |
50 |
211 |
0.0003916 |
0.002258 |
808 |
REGULATION OF DEFENSE RESPONSE |
146 |
759 |
0.0003955 |
0.002275 |
809 |
POSITIVE REGULATION OF CYTOKINE PRODUCTION |
79 |
370 |
0.000395 |
0.002275 |
810 |
MULTI ORGANISM REPRODUCTIVE PROCESS |
168 |
891 |
0.0004059 |
0.002331 |
811 |
PROTEIN LOCALIZATION TO MEMBRANE |
80 |
376 |
0.000408 |
0.002341 |
812 |
CARDIAC VENTRICLE MORPHOGENESIS |
20 |
62 |
0.0004094 |
0.002343 |
813 |
REGULATION OF TISSUE REMODELING |
20 |
62 |
0.0004094 |
0.002343 |
814 |
EPHRIN RECEPTOR SIGNALING PATHWAY |
25 |
85 |
0.0004149 |
0.002371 |
815 |
CARDIAC SEPTUM MORPHOGENESIS |
17 |
49 |
0.0004209 |
0.002403 |
816 |
NEGATIVE REGULATION OF AMINE TRANSPORT |
11 |
25 |
0.0004326 |
0.002467 |
817 |
REGULATION OF OXIDOREDUCTASE ACTIVITY |
26 |
90 |
0.0004372 |
0.00249 |
818 |
POTASSIUM ION HOMEOSTASIS |
9 |
18 |
0.0004561 |
0.002585 |
819 |
RESPONSE TO CAFFEINE |
9 |
18 |
0.0004561 |
0.002585 |
820 |
TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY |
27 |
95 |
0.000456 |
0.002585 |
821 |
OSTEOBLAST DEVELOPMENT |
9 |
18 |
0.0004561 |
0.002585 |
822 |
REGULATION OF LIPID STORAGE |
15 |
41 |
0.0004747 |
0.002658 |
823 |
REGULATION OF MEMBRANE DEPOLARIZATION |
15 |
41 |
0.0004747 |
0.002658 |
824 |
REGULATION OF HEART MORPHOGENESIS |
12 |
29 |
0.0004742 |
0.002658 |
825 |
POSITIVE REGULATION OF CARTILAGE DEVELOPMENT |
12 |
29 |
0.0004742 |
0.002658 |
826 |
MULTICELLULAR ORGANISMAL HOMEOSTASIS |
61 |
272 |
0.0004701 |
0.002658 |
827 |
GLUTAMATE RECEPTOR SIGNALING PATHWAY |
15 |
41 |
0.0004747 |
0.002658 |
828 |
REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY |
15 |
41 |
0.0004747 |
0.002658 |
829 |
PEPTIDYL TYROSINE DEPHOSPHORYLATION |
28 |
100 |
0.0004713 |
0.002658 |
830 |
LIMBIC SYSTEM DEVELOPMENT |
28 |
100 |
0.0004713 |
0.002658 |
831 |
LACTATION |
15 |
41 |
0.0004747 |
0.002658 |
832 |
MATING |
14 |
37 |
0.0004898 |
0.002723 |
833 |
ACTIN POLYMERIZATION OR DEPOLYMERIZATION |
14 |
37 |
0.0004898 |
0.002723 |
834 |
REGULATION OF RECEPTOR INTERNALIZATION |
14 |
37 |
0.0004898 |
0.002723 |
835 |
REGULATION OF MUSCLE HYPERTROPHY |
14 |
37 |
0.0004898 |
0.002723 |
836 |
GLIAL CELL MIGRATION |
14 |
37 |
0.0004898 |
0.002723 |
837 |
CAMP MEDIATED SIGNALING |
14 |
37 |
0.0004898 |
0.002723 |
838 |
RESPONSE TO CORTICOSTEROID |
43 |
176 |
0.0004913 |
0.002728 |
839 |
PATTERN SPECIFICATION PROCESS |
87 |
418 |
0.0004955 |
0.002748 |
840 |
RESPONSE TO CALCIUM ION |
31 |
115 |
0.0004982 |
0.002759 |
841 |
REGULATION OF OSTEOCLAST DIFFERENTIATION |
20 |
63 |
0.0005175 |
0.002855 |
842 |
AMINOGLYCAN METABOLIC PROCESS |
41 |
166 |
0.0005179 |
0.002855 |
843 |
REGULATION OF MUSCLE ADAPTATION |
20 |
63 |
0.0005175 |
0.002855 |
844 |
REGULATION OF CELL KILLING |
20 |
63 |
0.0005175 |
0.002855 |
845 |
NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS |
8 |
15 |
0.0005495 |
0.003015 |
846 |
POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION |
8 |
15 |
0.0005495 |
0.003015 |
847 |
REGULATION OF N METHYL D ASPARTATE SELECTIVE GLUTAMATE RECEPTOR ACTIVITY |
8 |
15 |
0.0005495 |
0.003015 |
848 |
MEMBRANE REPOLARIZATION |
8 |
15 |
0.0005495 |
0.003015 |
849 |
CELLULAR RESPONSE TO CAMP |
17 |
50 |
0.0005508 |
0.003015 |
850 |
RESPONSE TO PROGESTERONE |
17 |
50 |
0.0005508 |
0.003015 |
851 |
ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY |
36 |
141 |
0.0005709 |
0.003121 |
852 |
REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN |
21 |
68 |
0.0005738 |
0.003126 |
853 |
NERVE DEVELOPMENT |
21 |
68 |
0.0005738 |
0.003126 |
854 |
REGULATION OF PHAGOCYTOSIS |
21 |
68 |
0.0005738 |
0.003126 |
855 |
AORTA MORPHOGENESIS |
10 |
22 |
0.0005761 |
0.003135 |
856 |
GLIAL CELL DIFFERENTIATION |
35 |
136 |
0.0005777 |
0.00314 |
857 |
KIDNEY MORPHOGENESIS |
24 |
82 |
0.00058 |
0.003149 |
858 |
POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION |
34 |
131 |
0.0005829 |
0.003161 |
859 |
POSITIVE REGULATION OF PHAGOCYTOSIS |
16 |
46 |
0.000597 |
0.003234 |
860 |
REGULATION OF PROTEIN COMPLEX ASSEMBLY |
79 |
375 |
0.0006032 |
0.003263 |
861 |
NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT |
7 |
12 |
0.0006125 |
0.003287 |
862 |
REGULATION OF BROWN FAT CELL DIFFERENTIATION |
7 |
12 |
0.0006125 |
0.003287 |
863 |
REGULATION OF FATTY ACID METABOLIC PROCESS |
25 |
87 |
0.0006091 |
0.003287 |
864 |
CELLULAR RESPONSE TO EPINEPHRINE STIMULUS |
7 |
12 |
0.0006125 |
0.003287 |
865 |
REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS |
25 |
87 |
0.0006091 |
0.003287 |
866 |
POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC |
7 |
12 |
0.0006125 |
0.003287 |
867 |
POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY |
7 |
12 |
0.0006125 |
0.003287 |
868 |
NEGATIVE REGULATION OF MITOTIC CELL CYCLE |
47 |
199 |
0.0006211 |
0.00333 |
869 |
REGULATION OF CATABOLIC PROCESS |
140 |
731 |
0.0006221 |
0.003331 |
870 |
ASSOCIATIVE LEARNING |
22 |
73 |
0.0006236 |
0.003335 |
871 |
DEPHOSPHORYLATION |
63 |
286 |
0.0006314 |
0.003373 |
872 |
POSITIVE REGULATION OF GLUCOSE TRANSPORT |
15 |
42 |
0.0006384 |
0.003403 |
873 |
AUTONOMIC NERVOUS SYSTEM DEVELOPMENT |
15 |
42 |
0.0006384 |
0.003403 |
874 |
REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL |
18 |
55 |
0.0006454 |
0.003436 |
875 |
REGULATION OF AMINO ACID TRANSPORT |
11 |
26 |
0.0006502 |
0.003458 |
876 |
RENAL TUBULE DEVELOPMENT |
23 |
78 |
0.0006667 |
0.003541 |
877 |
SMOOTH MUSCLE CELL DIFFERENTIATION |
12 |
30 |
0.0006848 |
0.003621 |
878 |
EMBRYONIC SKELETAL SYSTEM DEVELOPMENT |
32 |
122 |
0.0006844 |
0.003621 |
879 |
REGULATION OF NEURON MIGRATION |
12 |
30 |
0.0006848 |
0.003621 |
880 |
LAMELLIPODIUM ASSEMBLY |
12 |
30 |
0.0006848 |
0.003621 |
881 |
POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION |
13 |
34 |
0.0006887 |
0.003629 |
882 |
REGULATION OF MESENCHYMAL CELL PROLIFERATION |
13 |
34 |
0.0006887 |
0.003629 |
883 |
HEART VALVE DEVELOPMENT |
13 |
34 |
0.0006887 |
0.003629 |
884 |
ORGAN REGENERATION |
24 |
83 |
0.0007031 |
0.003701 |
885 |
REGULATION OF DEPHOSPHORYLATION |
39 |
158 |
0.0007077 |
0.003721 |
886 |
SYNAPSE ASSEMBLY |
21 |
69 |
0.0007114 |
0.003736 |
887 |
POSITIVE REGULATION OF FAT CELL DIFFERENTIATION |
17 |
51 |
0.0007137 |
0.00374 |
888 |
NEGATIVE REGULATION OF CHEMOTAXIS |
17 |
51 |
0.0007137 |
0.00374 |
889 |
REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY |
38 |
153 |
0.000725 |
0.003794 |
890 |
REGULATION OF MONOOXYGENASE ACTIVITY |
19 |
60 |
0.0007321 |
0.003827 |
891 |
RESPONSE TO MUSCLE STRETCH |
9 |
19 |
0.0007532 |
0.00392 |
892 |
MACROPHAGE DIFFERENTIATION |
9 |
19 |
0.0007532 |
0.00392 |
893 |
REGULATION OF LONG TERM SYNAPTIC POTENTIATION |
9 |
19 |
0.0007532 |
0.00392 |
894 |
POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION |
9 |
19 |
0.0007532 |
0.00392 |
895 |
EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS |
26 |
93 |
0.0007569 |
0.003922 |
896 |
REGULATION OF DNA BINDING |
26 |
93 |
0.0007569 |
0.003922 |
897 |
MULTICELLULAR ORGANISM METABOLIC PROCESS |
26 |
93 |
0.0007569 |
0.003922 |
898 |
POSITIVE REGULATION OF BLOOD CIRCULATION |
26 |
93 |
0.0007569 |
0.003922 |
899 |
POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS |
16 |
47 |
0.0007822 |
0.004044 |
900 |
POSITIVE REGULATION OF DEPHOSPHORYLATION |
16 |
47 |
0.0007822 |
0.004044 |
901 |
REGULATION OF PHOSPHATASE ACTIVITY |
33 |
128 |
0.0007896 |
0.004078 |
902 |
NEGATIVE REGULATION OF PROTEIN SECRETION |
29 |
108 |
0.0007959 |
0.004106 |
903 |
MULTICELLULAR ORGANISMAL MACROMOLECULE METABOLIC PROCESS |
23 |
79 |
0.0008107 |
0.004178 |
904 |
RESPONSE TO STARVATION |
38 |
154 |
0.0008276 |
0.00426 |
905 |
APOPTOTIC SIGNALING PATHWAY |
63 |
289 |
0.0008374 |
0.004306 |
906 |
REGULATION OF MUSCLE CELL APOPTOTIC PROCESS |
15 |
43 |
0.0008478 |
0.004349 |
907 |
CELL FATE DETERMINATION |
15 |
43 |
0.0008478 |
0.004349 |
908 |
GLUCOSE HOMEOSTASIS |
41 |
170 |
0.0008624 |
0.00441 |
909 |
NEGATIVE REGULATION OF TRANSFERASE ACTIVITY |
74 |
351 |
0.0008613 |
0.00441 |
910 |
CARBOHYDRATE HOMEOSTASIS |
41 |
170 |
0.0008624 |
0.00441 |
911 |
INTERFERON GAMMA MEDIATED SIGNALING PATHWAY |
21 |
70 |
0.0008766 |
0.004477 |
912 |
RESPONSE TO INCREASED OXYGEN LEVELS |
10 |
23 |
0.0008849 |
0.004495 |
913 |
REGULATION OF OSTEOBLAST PROLIFERATION |
10 |
23 |
0.0008849 |
0.004495 |
914 |
RESPONSE TO HYPEROXIA |
10 |
23 |
0.0008849 |
0.004495 |
915 |
REGULATION OF RESPIRATORY GASEOUS EXCHANGE |
10 |
23 |
0.0008849 |
0.004495 |
916 |
INNERVATION |
10 |
23 |
0.0008849 |
0.004495 |
917 |
NEGATIVE CHEMOTAXIS |
14 |
39 |
0.0009056 |
0.004595 |
918 |
MYELOID LEUKOCYTE MIGRATION |
27 |
99 |
0.0009178 |
0.004647 |
919 |
OVARIAN FOLLICLE DEVELOPMENT |
19 |
61 |
0.0009178 |
0.004647 |
920 |
REGULATION OF RESPIRATORY SYSTEM PROCESS |
8 |
16 |
0.0009569 |
0.004783 |
921 |
REGULATION OF SMAD PROTEIN IMPORT INTO NUCLEUS |
8 |
16 |
0.0009569 |
0.004783 |
922 |
HIPPO SIGNALING |
11 |
27 |
0.0009517 |
0.004783 |
923 |
BONE REMODELING |
13 |
35 |
0.0009488 |
0.004783 |
924 |
POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY |
8 |
16 |
0.0009569 |
0.004783 |
925 |
RESPONSE TO EPINEPHRINE |
8 |
16 |
0.0009569 |
0.004783 |
926 |
SUBSTRATE DEPENDENT CELL MIGRATION |
11 |
27 |
0.0009517 |
0.004783 |
927 |
ORGANELLE LOCALIZATION |
85 |
415 |
0.0009533 |
0.004783 |
928 |
BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS |
8 |
16 |
0.0009569 |
0.004783 |
929 |
POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT |
11 |
27 |
0.0009517 |
0.004783 |
930 |
MONOCYTE DIFFERENTIATION |
8 |
16 |
0.0009569 |
0.004783 |
931 |
REGULATION OF FATTY ACID BETA OXIDATION |
8 |
16 |
0.0009569 |
0.004783 |
932 |
ADULT WALKING BEHAVIOR |
12 |
31 |
0.0009682 |
0.004818 |
933 |
CARDIAC ATRIUM DEVELOPMENT |
12 |
31 |
0.0009682 |
0.004818 |
934 |
POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY |
12 |
31 |
0.0009682 |
0.004818 |
935 |
WALKING BEHAVIOR |
12 |
31 |
0.0009682 |
0.004818 |
936 |
INSULIN RECEPTOR SIGNALING PATHWAY |
23 |
80 |
0.000981 |
0.004877 |
937 |
ADENYLATE CYCLASE MODULATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY |
36 |
145 |
0.0009919 |
0.004926 |
938 |
MYOFIBRIL ASSEMBLY |
16 |
48 |
0.001014 |
0.005026 |
939 |
POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION |
16 |
48 |
0.001014 |
0.005026 |
940 |
CARDIAC SEPTUM DEVELOPMENT |
24 |
85 |
0.001019 |
0.005038 |
941 |
REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION |
24 |
85 |
0.001019 |
0.005038 |
942 |
NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION |
34 |
135 |
0.001035 |
0.005111 |
943 |
SYNAPTIC VESICLE CYCLE |
25 |
90 |
0.001048 |
0.00516 |
944 |
ENDOTHELIUM DEVELOPMENT |
25 |
90 |
0.001048 |
0.00516 |
945 |
ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE |
25 |
90 |
0.001048 |
0.00516 |
946 |
PHOSPHATIDYLINOSITOL METABOLIC PROCESS |
45 |
193 |
0.001063 |
0.005229 |
947 |
REGULATION OF TRANSCRIPTION FACTOR IMPORT INTO NUCLEUS |
26 |
95 |
0.001069 |
0.005253 |
948 |
REGULATION OF ACTIN FILAMENT LENGTH |
38 |
156 |
0.001072 |
0.005254 |
949 |
SKIN EPIDERMIS DEVELOPMENT |
21 |
71 |
0.001074 |
0.005254 |
950 |
ADHERENS JUNCTION ORGANIZATION |
21 |
71 |
0.001074 |
0.005254 |
951 |
PROTEIN LOCALIZATION TO NUCLEUS |
38 |
156 |
0.001072 |
0.005254 |
952 |
G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER |
41 |
172 |
0.001101 |
0.00538 |
953 |
BRANCHING INVOLVED IN URETERIC BUD MORPHOGENESIS |
15 |
44 |
0.001112 |
0.005432 |
954 |
POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION |
75 |
360 |
0.00113 |
0.005513 |
955 |
REGULATION OF CALCIUM MEDIATED SIGNALING |
22 |
76 |
0.001133 |
0.005516 |
956 |
NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION |
36 |
146 |
0.001132 |
0.005516 |
957 |
RELAXATION OF CARDIAC MUSCLE |
7 |
13 |
0.001158 |
0.005588 |
958 |
VASCULAR SMOOTH MUSCLE CELL DIFFERENTIATION |
7 |
13 |
0.001158 |
0.005588 |
959 |
REGULATION OF PHAGOCYTOSIS ENGULFMENT |
7 |
13 |
0.001158 |
0.005588 |
960 |
EYELID DEVELOPMENT IN CAMERA TYPE EYE |
7 |
13 |
0.001158 |
0.005588 |
961 |
NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY |
7 |
13 |
0.001158 |
0.005588 |
962 |
SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE |
7 |
13 |
0.001158 |
0.005588 |
963 |
REGULATION OF MEMBRANE INVAGINATION |
7 |
13 |
0.001158 |
0.005588 |
964 |
EXTRACELLULAR FIBRIL ORGANIZATION |
7 |
13 |
0.001158 |
0.005588 |
965 |
POSITIVE REGULATION OF FIBROBLAST PROLIFERATION |
17 |
53 |
0.001165 |
0.005601 |
966 |
REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS |
17 |
53 |
0.001165 |
0.005601 |
967 |
NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION |
17 |
53 |
0.001165 |
0.005601 |
968 |
MESONEPHRIC TUBULE MORPHOGENESIS |
17 |
53 |
0.001165 |
0.005601 |
969 |
REGULATION OF FIBROBLAST PROLIFERATION |
23 |
81 |
0.001181 |
0.005672 |
970 |
REFLEX |
9 |
20 |
0.001191 |
0.005694 |
971 |
RESPONSE TO PROTOZOAN |
9 |
20 |
0.001191 |
0.005694 |
972 |
RELAXATION OF MUSCLE |
9 |
20 |
0.001191 |
0.005694 |
973 |
MELANOCYTE DIFFERENTIATION |
9 |
20 |
0.001191 |
0.005694 |
974 |
POSITIVE REGULATION OF CELL MATRIX ADHESION |
14 |
40 |
0.001206 |
0.005754 |
975 |
REGULATION OF FILOPODIUM ASSEMBLY |
14 |
40 |
0.001206 |
0.005754 |
976 |
CELL MATURATION |
33 |
131 |
0.001211 |
0.005773 |
977 |
POSITIVE REGULATION OF DNA REPLICATION |
24 |
86 |
0.001218 |
0.005802 |
978 |
POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT |
61 |
282 |
0.001224 |
0.005822 |
979 |
SYNAPTIC VESICLE LOCALIZATION |
28 |
106 |
0.001276 |
0.006059 |
980 |
CARDIAC VENTRICLE DEVELOPMENT |
28 |
106 |
0.001276 |
0.006059 |
981 |
LAMELLIPODIUM ORGANIZATION |
13 |
36 |
0.001286 |
0.006088 |
982 |
INTRACELLULAR RECEPTOR SIGNALING PATHWAY |
40 |
168 |
0.001286 |
0.006088 |
983 |
REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING |
13 |
36 |
0.001286 |
0.006088 |
984 |
POSITIVE REGULATION OF CELL ACTIVATION |
66 |
311 |
0.001332 |
0.006298 |
985 |
POSITIVE REGULATION OF LIPID KINASE ACTIVITY |
12 |
32 |
0.001343 |
0.006323 |
986 |
POSITIVE REGULATION OF DENDRITE MORPHOGENESIS |
12 |
32 |
0.001343 |
0.006323 |
987 |
REGULATION OF ACTIN CYTOSKELETON REORGANIZATION |
12 |
32 |
0.001343 |
0.006323 |
988 |
ADIPOSE TISSUE DEVELOPMENT |
12 |
32 |
0.001343 |
0.006323 |
989 |
CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER |
11 |
28 |
0.00136 |
0.006398 |
990 |
REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY |
22 |
77 |
0.001369 |
0.006432 |
991 |
NEUROEPITHELIAL CELL DIFFERENTIATION |
19 |
63 |
0.001412 |
0.006631 |
992 |
POSITIVE REGULATION OF RECEPTOR ACTIVITY |
15 |
45 |
0.001443 |
0.00675 |
993 |
SMOOTH MUSCLE CONTRACTION |
15 |
45 |
0.001443 |
0.00675 |
994 |
HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES |
15 |
45 |
0.001443 |
0.00675 |
995 |
ENDOCHONDRAL BONE MORPHOGENESIS |
15 |
45 |
0.001443 |
0.00675 |
996 |
POSITIVE REGULATION OF DNA METABOLIC PROCESS |
43 |
185 |
0.001445 |
0.006751 |
997 |
POSITIVE REGULATION OF ORGANELLE ORGANIZATION |
111 |
573 |
0.001455 |
0.00679 |
998 |
CELLULAR RESPONSE TO STARVATION |
30 |
117 |
0.001463 |
0.006822 |
999 |
RESPONSE TO TRANSITION METAL NANOPARTICLE |
36 |
148 |
0.001467 |
0.006831 |
1000 |
ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY |
20 |
68 |
0.001507 |
0.007013 |
1001 |
ORGANIC ANION TRANSPORT |
79 |
387 |
0.001554 |
0.007223 |
1002 |
REGULATION OF PROTEIN KINASE A SIGNALING |
8 |
17 |
0.001574 |
0.007267 |
1003 |
POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT |
8 |
17 |
0.001574 |
0.007267 |
1004 |
NEGATIVE REGULATION OF LIPID STORAGE |
8 |
17 |
0.001574 |
0.007267 |
1005 |
MAMMARY GLAND ALVEOLUS DEVELOPMENT |
8 |
17 |
0.001574 |
0.007267 |
1006 |
MAMMARY GLAND LOBULE DEVELOPMENT |
8 |
17 |
0.001574 |
0.007267 |
1007 |
COPULATION |
8 |
17 |
0.001574 |
0.007267 |
1008 |
ACTIVATION OF PROTEIN KINASE A ACTIVITY |
8 |
17 |
0.001574 |
0.007267 |
1009 |
HIPPOCAMPUS DEVELOPMENT |
21 |
73 |
0.001584 |
0.007298 |
1010 |
REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION |
21 |
73 |
0.001584 |
0.007298 |
1011 |
REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS |
18 |
59 |
0.001614 |
0.007427 |
1012 |
REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS |
22 |
78 |
0.001644 |
0.00756 |
1013 |
REGULATION OF ORGANIC ACID TRANSPORT |
16 |
50 |
0.001655 |
0.007581 |
1014 |
ENDODERM FORMATION |
16 |
50 |
0.001655 |
0.007581 |
1015 |
NEGATIVE REGULATION OF WNT SIGNALING PATHWAY |
45 |
197 |
0.001652 |
0.007581 |
1016 |
RHO PROTEIN SIGNAL TRANSDUCTION |
16 |
50 |
0.001655 |
0.007581 |
1017 |
PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY |
23 |
83 |
0.001689 |
0.007722 |
1018 |
MESODERM DEVELOPMENT |
30 |
118 |
0.001689 |
0.007722 |
1019 |
NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE |
13 |
37 |
0.001717 |
0.007827 |
1020 |
REGULATION OF MEMBRANE LIPID DISTRIBUTION |
13 |
37 |
0.001717 |
0.007827 |
1021 |
REGULATION OF PROTEIN AUTOPHOSPHORYLATION |
13 |
37 |
0.001717 |
0.007827 |
1022 |
CELLULAR RESPONSE TO INTERLEUKIN 1 |
24 |
88 |
0.001719 |
0.007828 |
1023 |
REGULATION OF NEUROTRANSMITTER TRANSPORT |
19 |
64 |
0.001734 |
0.007888 |
1024 |
REGULATION OF RUFFLE ASSEMBLY |
9 |
21 |
0.001812 |
0.008211 |
1025 |
REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS |
9 |
21 |
0.001812 |
0.008211 |
1026 |
BONE RESORPTION |
9 |
21 |
0.001812 |
0.008211 |
1027 |
NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT |
9 |
21 |
0.001812 |
0.008211 |
1028 |
ORGANIC HYDROXY COMPOUND TRANSPORT |
37 |
155 |
0.00182 |
0.008228 |
1029 |
REGULATION OF CYCLIC NUCLEOTIDE METABOLIC PROCESS |
37 |
155 |
0.00182 |
0.008228 |
1030 |
EMBRYONIC DIGESTIVE TRACT DEVELOPMENT |
12 |
33 |
0.001829 |
0.008263 |
1031 |
POSITIVE REGULATION OF CATABOLIC PROCESS |
80 |
395 |
0.001833 |
0.008272 |
1032 |
NEGATIVE REGULATION OF DNA BINDING |
15 |
46 |
0.001853 |
0.008346 |
1033 |
PEPTIDYL THREONINE MODIFICATION |
15 |
46 |
0.001853 |
0.008346 |
1034 |
NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE |
11 |
29 |
0.001901 |
0.008546 |
1035 |
EMBRYONIC HINDLIMB MORPHOGENESIS |
11 |
29 |
0.001901 |
0.008546 |
1036 |
REGULATION OF ACUTE INFLAMMATORY RESPONSE |
21 |
74 |
0.001909 |
0.008565 |
1037 |
CHONDROITIN SULFATE BIOSYNTHETIC PROCESS |
10 |
25 |
0.001907 |
0.008565 |
1038 |
POSITIVE REGULATION OF HORMONE SECRETION |
30 |
119 |
0.001945 |
0.008719 |
1039 |
REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY |
29 |
114 |
0.001979 |
0.008863 |
1040 |
CELL MIGRATION INVOLVED IN HEART DEVELOPMENT |
7 |
14 |
0.002021 |
0.008981 |
1041 |
POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION |
7 |
14 |
0.002021 |
0.008981 |
1042 |
AMINO ACID BETAINE TRANSPORT |
7 |
14 |
0.002021 |
0.008981 |
1043 |
INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY |
7 |
14 |
0.002021 |
0.008981 |
1044 |
METANEPHRIC MESENCHYME DEVELOPMENT |
7 |
14 |
0.002021 |
0.008981 |
1045 |
POSITIVE REGULATION OF CELL SIZE |
7 |
14 |
0.002021 |
0.008981 |
1046 |
REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY |
7 |
14 |
0.002021 |
0.008981 |
1047 |
REGULATION OF SYNAPSE MATURATION |
7 |
14 |
0.002021 |
0.008981 |
1048 |
EPITHELIAL CELL PROLIFERATION |
24 |
89 |
0.00203 |
0.009004 |
1049 |
POST EMBRYONIC DEVELOPMENT |
24 |
89 |
0.00203 |
0.009004 |
1050 |
STRIATED MUSCLE CONTRACTION |
26 |
99 |
0.002039 |
0.009035 |
1051 |
REGULATION OF LEUKOCYTE MEDIATED IMMUNITY |
37 |
156 |
0.002052 |
0.009085 |
1052 |
LIPID MODIFICATION |
47 |
210 |
0.002057 |
0.009093 |
1053 |
EPITHELIAL CELL MORPHOGENESIS |
14 |
42 |
0.002058 |
0.009093 |
1054 |
RESPONSE TO AMMONIUM ION |
16 |
51 |
0.002086 |
0.009199 |
1055 |
REGULATION OF INTERLEUKIN 12 PRODUCTION |
16 |
51 |
0.002086 |
0.009199 |
1056 |
LEUKOCYTE CELL CELL ADHESION |
55 |
255 |
0.002204 |
0.009712 |
1057 |
CELLULAR RESPONSE TO GLUCAGON STIMULUS |
13 |
38 |
0.002262 |
0.009946 |
1058 |
REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY |
13 |
38 |
0.002262 |
0.009946 |